subject: UMLS:C2183198


subject: UMLS:C2183198

subject_name: diagnostic drugs renal inulin

object_name: periodontitis

tested_intervention: unsure


subject: CHEBI:41774

subject_name: Tamoxifen

object_name: atypical lobular breast hyperplasia

tested_intervention: yes


subject: CHEBI:92076

subject_name: AFIMOXIFENE

object_name: breast carcinoma


subject: CHEBI:92076

object_name: lobular breast carcinoma in situ


subject: CHEBI:92076

object_name: Atypical hyperplasia of breast


subject: CHEBI:92076


subject: CHEBI:231618


subject: CHEBI:231618


subject: CHEBI:231618


subject: CHEBI:231618


subject: PUBCHEM.COMPOUND:54580717

subject_name: KARENITECIN

object_name: brain neoplasm


subject: PUBCHEM.COMPOUND:54580717

object_name: brain cancer


subject: CHEBI:177492

subject_name: Cositecan


subject: CHEBI:177492


subject: UMLS:C0913202


subject: UMLS:C0913202


subject: UNII:K0XHQ9FYT3

subject_name: BK-MDA

object_name: prostate cancer


subject: UNII:K0XHQ9FYT3

object_name: prostate neoplasm


subject: PR:000003710

subject_name: disintegrin and metalloproteinase domain-containing protein 11


subject: PR:000003710


subject: PR:000001994

subject_name: C-C motif chemokine 22


subject: PR:000001994


subject: CHEBI:47381

subject_name: Diclofenac

object_name: Sports Injury


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Recurrent Meningioma


subject: UNII:DPT0O3T46P

object_name: Adult Grade II Meningioma


subject: UNII:DPT0O3T46P

object_name: Adult Grade I Meningioma


subject: UNII:DPT0O3T46P

object_name: Adult Grade III Meningioma


subject: GTOPDB:9589

subject_name: enoblituzumab

object_name: prostate carcinoma


subject: GTOPDB:9589


subject: CHEMBL.COMPOUND:CHEMBL3545373

subject_name: ENOBLITUZUMAB


subject: CHEMBL.COMPOUND:CHEMBL3545373


subject: UMLS:C3273458


subject: UMLS:C3273458


subject: GTOPDB:9758

subject_name: camrelizumab

object_name: Neck Carcinoma


subject: GTOPDB:9758

object_name: head and neck neoplasm


subject: GTOPDB:9758

object_name: head and neck cancer


subject: UNII:73096E137E


subject: UNII:73096E137E


subject: UNII:73096E137E


subject: UMLS:C4085979


subject: UMLS:C4085979


subject: UMLS:C4085979


subject: CHEBI:6030

subject_name: Isoniazid

object_name: female infertility


subject: UMLS:C5203351

subject_name: Furosemide Liquid Injection

object_name: cardio-renal syndrome


subject: UMLS:C4048177

subject_name: furosemide injection


subject: CHEBI:47426

subject_name: Furosemide


subject: PUBCHEM.COMPOUND:16129681

subject_name: Ghrih-A

object_name: acute pancreatitis


subject: PUBCHEM.COMPOUND:53481605

subject_name: Somatostatin


subject: CHEBI:119915

subject_name: Fentanyl

object_name: Low back pain


subject: UMLS:C1566002

subject_name: Embosphere Microspheres

object_name: Secondary malignant neoplasm of lung


subject: UMLS:C1566002

object_name: Metastatic malignant neoplasm to pleura


subject: UMLS:C1566002

object_name: Metastatic malignant neoplasm to mediastinum


subject: UMLS:C1566002

object_name: Endobronchial metastases


subject: UMLS:C0947677

subject_name: Lipiodol


subject: UMLS:C0947677


subject: UMLS:C0947677


subject: UMLS:C0947677


subject: CHEBI:194095

subject_name: mitomycin C(1-)


subject: CHEBI:194095


subject: CHEBI:194095


subject: CHEBI:194095


subject: CHEBI:27504

subject_name: Mitomycin


subject: CHEBI:27504


subject: CHEBI:27504


subject: CHEBI:27504


subject: CHEBI:9316

subject_name: Sufentanil

object_name: Mobility finding


subject: UMLS:C5552956

subject_name: Direct Oral Anticoagulant

object_name: Embolism and thrombosis of the renal vein


subject: UMLS:C5552956

object_name: Renal vein thrombosis


subject: UMLS:C5552956

object_name: retinal vein occlusion


subject: UMLS:C5552956

object_name: Ovarian vein thrombosis


subject: UMLS:C5552956

object_name: Cerebral Venous Thrombosis Related to COVID-19


subject: UMLS:C5552956

object_name: Cerebral venous thrombosis


subject: UMLS:C5552956

object_name: Splanchnic vein thrombosis


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: bariatric surgery candidate


subject: CHEBI:6801

subject_name: Metformin

object_name: Impacted third molar tooth


subject: CHEBI:127342

subject_name: Atomoxetine

object_name: cocaine abuse


subject: CHEBI:72544

subject_name: flavonoids

object_name: Well adult


subject: CHEBI:47916

subject_name: flavonoid


subject: UMLS:C0125061

subject_name: L-NDDP

object_name: malignant mesothelioma


subject: UMLS:C2830052

object_name: adult lymphoma


subject: UMLS:C2830052

object_name: lymphoma


subject: UMLS:C2830052

object_name: pediatric lymphoma


subject: CHEMBL.COMPOUND:CHEMBL2109625

object_name: Acute flaccid paralysis


subject: CHEMBL.COMPOUND:CHEMBL2109625

object_name: encephalitis


subject: CHEMBL.COMPOUND:CHEMBL2109625

object_name: meningitis


subject: CHEMBL.COMPOUND:CHEMBL2109625

object_name: Meningitis, CTCAE


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Lack of drug action


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: CHEBI:32599


subject: UMLS:C4722471

object_name: small cell lung carcinoma


subject: UNII:YET2XNU791


subject: UNII:YET2XNU791


subject: UNII:YET2XNU791


subject: UNII:YET2XNU791

object_name: Adult Solid Neoplasm


subject: UMLS:C5418168

subject_name: Fadraciclib


subject: UMLS:C5418168


subject: UMLS:C5418168


subject: UMLS:C5418168


subject: MESH:C406630

subject_name: Oxiplex

object_name: Asherman syndrome


subject: UMLS:C5785353

object_name: Erectile dysfunction following radical prostatectomy


subject: UMLS:C5785353

object_name: impotence


subject: UMLS:C5785353

object_name: Erectile Dysfunction, CTCAE


subject: UMLS:C5785353

object_name: Erectile dysfunction


subject: UMLS:C5785353

object_name: prostate carcinoma


subject: UMLS:C5785353

object_name: prostate cancer


subject: CHEBI:134736

subject_name: Vintafolide

object_name: Childhood Solid Neoplasm


subject: CHEBI:134736


subject: CHEBI:192614

subject_name: Homosildenafil

object_name: endogenous depression


subject: CHEBI:192614

object_name: major depressive disorder


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: UNII:L6WO34R9YG


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: PUBCHEM.COMPOUND:131769997


subject: CHEBI:183660

subject_name: Acetildenafil


subject: CHEBI:183660


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: UNII:80X7B1F6NW


subject: CHEBI:9139

subject_name: Sildenafil


subject: CHEBI:9139


subject: UNII:9M85GXG84D

subject_name: NERAMEXANE MESYLATE

object_name: multiple sclerosis


subject: UNII:9M85GXG84D

object_name: congenital nystagmus


subject: UNII:9M85GXG84D

object_name: Acquired nystagmus


subject: UMLS:C2698449

subject_name: Neramexane Mesylate


subject: UMLS:C2698449


subject: UMLS:C2698449


subject: CHEBI:4466

object_name: perinatal asphyxia


subject: CHEBI:4466

object_name: Neonatal hypoxic and ischemic brain injury


subject: CHEBI:4466

object_name: Hypoxic-Ischemic Encephalopathy


subject: CHEBI:4466

object_name: Hypoxic Ischemic Encephalopathy, AE


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: CHEBI:95346

subject_name: Atovaquone

object_name: rabies


subject: CHEBI:8455

subject_name: Proguanil


subject: CHEBI:3638

subject_name: Chloroquine


subject: CHEBI:60648

subject_name: DOXYCYCLINE


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline


subject: UMLS:C0301532

subject_name: Multivitamin preparation

object_name: tuberculosis


subject: UMLS:C3714835

subject_name: Multivitamin Drug Class


subject: UMLS:C5959686

subject_name: MIF Inhibitor IPG1094


subject: UMLS:C5959686

object_name: Adult Solid Neoplasm


subject: UMLS:C5959686

object_name: Solid Neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4297239

subject_name: DILANUBICEL

object_name: acute biphenotypic leukemia


subject: CHEMBL.COMPOUND:CHEMBL4297239

object_name: Infant Acute Biphenotypic Leukemia


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:230470

subject_name: rezafungin acetate

object_name: Invasive fungal infection


subject: UNII:W1U1TMN677

subject_name: Biafungin acetate


subject: CHEBI:229680

subject_name: Rezafungin


subject: PUBCHEM.COMPOUND:9829502

subject_name: Emricasan

object_name: fibrosis


subject: PUBCHEM.COMPOUND:9829502

object_name: liver disorder


subject: CHEBI:73896

subject_name: Gly-D-Thr

object_name: hypertension


subject: CHEBI:73896

object_name: Hypertension, CTCAE


subject: CHEBI:73920

subject_name: Gly-Thr


subject: CHEBI:73920


subject: CHEBI:87681

subject_name: Ranolazine

object_name: polyneuropathy


subject: CHEBI:87681

object_name: peripheral nervous system disorder


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: drug-induced liver injury


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: PUBCHEM.COMPOUND:155543961

subject_name: LIRAGLUTIDE

object_name: COPD, severe early onset


subject: PUBCHEM.COMPOUND:155543961

object_name: chronic obstructive pulmonary disease


subject: UMLS:C1099192


subject: UMLS:C1099192


subject: UNII:48IJA0E92C

subject_name: IFETROBAN SODIUM

object_name: Childhood Malignant Solid Neoplasm


subject: UNII:48IJA0E92C

object_name: Malignant Solid Neoplasm


subject: UMLS:C2825686

subject_name: Ifetroban Sodium


subject: UMLS:C2825686


subject: UNII:2O4BE0K238

subject_name: Volanesorsen

object_name: familial chylomicronemia syndrome


subject: CHEBI:75551

object_name: Nonulcer dyspepsia


subject: UNII:7XL5ISS668

subject_name: Adcetris

object_name: leukemia


subject: UNII:7XL5ISS668

object_name: childhood leukemia


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: UMLS:C5784825

subject_name: EGFR Mutant-selective Inhibitor QLH11811

object_name: non-small cell lung carcinoma


subject: UMLS:C0885467

subject_name: Juglans regia preparation

object_name: age-related macular degeneration


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: adult germ cell tumor


subject: UNII:28X28X9OKV

object_name: germ cell tumor


subject: UNII:28X28X9OKV

object_name: childhood germ cell tumor


subject: UNII:28X28X9OKV

object_name: Germ Cell Cancer


subject: UNII:28X28X9OKV

object_name: malignant pineal area germ cell neoplasm


subject: UNII:28X28X9OKV

object_name: germinomatous germ cell tumor


subject: UNII:28X28X9OKV

object_name: Childhood Germinomatous Germ Cell Tumor


subject: UNII:28X28X9OKV

object_name: nongerminomatous germ cell tumor


subject: UNII:28X28X9OKV

object_name: dysgerminoma of ovary


subject: UNII:28X28X9OKV

object_name: dysgerminoma


subject: UNII:28X28X9OKV

object_name: seminoma


subject: UNII:28X28X9OKV

object_name: testicular germ cell tumor


subject: UNII:28X28X9OKV

object_name: testis seminoma


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UNII:QEN1X95CIX

subject_name: Tremelimumab


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: CHEBI:5856

subject_name: Ibutilide

object_name: persistent atrial fibrillation


subject: CHEBI:5856

object_name: Persistent Atrial Fibrillation by ECG Finding


subject: GTOPDB:9615

object_name: melanoma


subject: UMLS:C3658787


subject: CHEBI:31348

subject_name: Capecitabine


subject: UMLS:C4722367


subject: DRUGBANK:DB17529


subject: DRUGBANK:DB17530


subject: UNII:FIJ3OLQ3N8


subject: UMLS:C2826130

subject_name: Recombinant Saccharomyces Cerevisia-CEA(610D)-Expressing Vaccine GI-6207


subject: UMLS:C4722124


subject: UNII:B0L24T8TB7


subject: UMLS:C5777124

subject_name: CD-16 NK-92 cells


subject: UMLS:C4552849

subject_name: haNK


subject: PUBCHEM.COMPOUND:9831414

subject_name: Lovaza


subject: UNII:D87YGH4Z0Q

subject_name: Omacor


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline

object_name: neurofibromatosis


subject: PUBCHEM.COMPOUND:54671203

object_name: NF2-related schwannomatosis


subject: PUBCHEM.COMPOUND:54671203

object_name: vestibular schwannomatosis


subject: UMLS:C1699394

subject_name: Hylenex


subject: PUBCHEM.COMPOUND:21634109

subject_name: Lacosamide

object_name: Partial Seizure


subject: PUBCHEM.COMPOUND:4442

subject_name: Ramosetron

object_name: Abdominal mass


subject: CHEBI:135738

subject_name: Clevidipine

object_name: Blood Pressure Finding


subject: CHEBI:135738

object_name: Systemic arterial pressure


subject: CHEBI:135738

object_name: Acute Stroke


subject: UNII:4VZT670SD9

subject_name: Ondelopran

object_name: alcohol abuse


subject: UNII:4VZT670SD9

object_name: alcohol dependence


subject: PR:000002327

subject_name: gelsolin isoform 1

object_name: osteoarthritis, knee


subject: CHEBI:124959

subject_name: Tilarginine

object_name: liver cirrhosis


subject: UMLS:C0069477


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UNII:X6T6YN87SU

subject_name: Potassium sodium hydrogen citrate

object_name: acute urate nephropathy


subject: CHEMBL.COMPOUND:CHEMBL4594488

subject_name: POTASSIUM SODIUM HYDROGEN CITRATE


subject: CHEBI:52717

subject_name: Bortezomib

object_name: renal pelvis/ureter urothelial carcinoma


subject: CHEBI:52717

object_name: bladder tumor


subject: CHEBI:52717

object_name: urinary bladder carcinoma


subject: CHEBI:52717

object_name: urinary bladder cancer


subject: CHEBI:52717

object_name: childhood bladder carcinoma


subject: PUBCHEM.COMPOUND:4474933

subject_name: Methylprednisolone aceponate

object_name: atopic eczema


subject: CHEBI:6888

subject_name: Methylprednisolone


subject: UMLS:C1527920

subject_name: Advantan


subject: UMLS:C5670599

subject_name: Anti-Claudin18.2 Monoclonal Antibody TORL-2-307-MAB

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C5670599

object_name: Stomach cancer


subject: UMLS:C5670599

object_name: gastric cancer


subject: UMLS:C5670599

object_name: pancreatic neoplasm


subject: UMLS:C5670599

object_name: exocrine pancreatic carcinoma


subject: UMLS:C5670599

object_name: malignant pancreatic neoplasm


subject: UMLS:C5670599


subject: CHEBI:49140

object_name: childhood neoplasm


subject: CHEBI:49134


subject: CHEBI:31617

subject_name: fludeoxyglucose (18F)


subject: CHEBI:6504

object_name: Sleep Deprivation


subject: CHEBI:87715

subject_name: Prasugrel

object_name: end stage renal failure


subject: CHEBI:87715

object_name: chronic kidney disease


subject: CHEBI:87715

object_name: Chronic uremia


subject: UMLS:C5706398

subject_name: ATR Inhibitor ATG-018

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:31312

subject_name: Bucillamine

object_name: rheumatoid arthritis


subject: CHEBI:233197

subject_name: devimistat

object_name: adult acute myeloid leukemia


subject: CHEBI:233197

object_name: childhood acute myeloid leukemia


subject: CHEBI:233197

object_name: acute myeloid leukemia


subject: CHEBI:233197

object_name: Myelodysplasia


subject: UMLS:C2703200

subject_name: CPI 613


subject: UMLS:C2703200


subject: UMLS:C2703200


subject: UMLS:C2703200


subject: PUBCHEM.COMPOUND:135449332

subject_name: Eltrombopag

object_name: Graft failure


subject: PUBCHEM.COMPOUND:135449332

object_name: leukemia


subject: PUBCHEM.COMPOUND:135449332

object_name: childhood leukemia


subject: UMLS:C0353681

subject_name: subcutaneous heparin

object_name: venous thromboembolism


subject: UMLS:C0353681

object_name: thrombophilia due to thrombin defect


subject: UMLS:C0353681

object_name: Deep Venous Thrombosis Related to COVID-19


subject: UMLS:C0353681

object_name: Deep venous thrombosis


subject: UMLS:C0353681

object_name: prostate carcinoma


subject: UMLS:C0353681

object_name: prostate cancer


subject: UMLS:C0353681

object_name: pulmonary embolism


subject: UMLS:C0353681

object_name: Lymphocele after surgical procedure


subject: CHEBI:141346

subject_name: Solabegron

object_name: Urinary Urgency


subject: PUBCHEM.COMPOUND:53477758

subject_name: Oxytocin

object_name: labor; forced or induced, affecting fetus or newborn


subject: UMLS:C0592155

subject_name: Syntocinon


subject: CHEBI:125628

subject_name: Alisertib

object_name: enteropathy-associated T-cell lymphoma


subject: CHEBI:125628

object_name: marginal zone lymphoma


subject: CHEBI:125628

object_name: diffuse large B-cell lymphoma


subject: CHEBI:125628

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: CHEBI:125628

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: CHEBI:125628

object_name: plasma cell myeloma


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL

object_name: kidney disorder


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C5239502

subject_name: Salovum

object_name: diarrhea


subject: UMLS:C5239502

object_name: rectal discharge diarrhea (physical finding)


subject: UMLS:C5239502

object_name: Diarrhea, CTCAE


subject: UMLS:C5239502

object_name: Early Stage Breast Carcinoma


subject: UMLS:C5239502

object_name: Adverse drug response


subject: CHEBI:9445

subject_name: Terazosin

object_name: carotid stenosis


subject: UMLS:C5960141

subject_name: Surabgene Lomparvovec

object_name: wet macular degeneration


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: Stomach cancer


subject: UNII:28X28X9OKV

object_name: gastric cancer


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UNII:QEN1X95CIX

subject_name: Tremelimumab


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX

object_name: gastric adenocarcinoma


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: CHEBI:45783

subject_name: Imatinib

object_name: scleroderma


subject: CHEBI:38721

subject_name: Methamidophos

object_name: triple-negative breast carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297694

subject_name: ANFIBATIDE

object_name: ST-elevation myocardial infarction


subject: UMLS:C3886764

subject_name: Anfibatide


subject: CHEBI:47808

subject_name: Sulforaphane

object_name: fragile x associated tremor/ataxia syndrome (FXTAS)


subject: UNII:53O87HA2QU

subject_name: Defactinib

object_name: lung cancer


subject: UNII:53O87HA2QU

object_name: lung neoplasm


subject: UMLS:C2703169


subject: UMLS:C2703169


subject: UMLS:C2703169

object_name: lung carcinoma


subject: UMLS:C2703169

object_name: non-small cell lung carcinoma


subject: CHEBI:36796

subject_name: duloxetine

object_name: Diabetic Neuralgia


subject: CHEBI:6801

subject_name: Metformin

object_name: body weight


subject: PUBCHEM.COMPOUND:11306691

subject_name: rac-Sitagliptin


subject: CHEBI:40237

subject_name: Sitagliptin


subject: CHEBI:85993

subject_name: Palbociclib


subject: PUBCHEM.COMPOUND:56776542

subject_name: Andecaliximab


subject: UNII:571045EIM4

subject_name: andecaliximab


subject: UMLS:C3827124


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: osteoarthritis


subject: CHEBI:6888

object_name: osteoarthritis susceptibility 1


subject: UNII:QEA2EG9S3E

subject_name: PUMITAMIG

object_name: breast neoplasm


subject: CHEBI:94771

subject_name: Quisinostat

object_name: Myelodysplasia


subject: UMLS:C2703097


subject: CHEBI:9150

subject_name: Simvastatin

object_name: rheumatic heart disease


subject: CHEBI:9150

object_name: congenital heart disease


subject: CHEBI:9150

object_name: heart valve disorder


subject: CHEBI:9150

object_name: aneurysm


subject: UMLS:C4722236

subject_name: Acacia senegal extract

object_name: Sickle cell anemia in children


subject: UMLS:C1136254

subject_name: Microbicides

object_name: denture stomatitis


subject: CHEBI:76842

object_name: Childhood Breast Carcinoma


subject: CHEBI:76842

object_name: breast carcinoma


subject: CHEBI:76842

object_name: breast cancer


subject: CHEBI:28001

subject_name: Vancomycin


subject: CHEBI:28001


subject: CHEBI:28001


subject: PUBCHEM.COMPOUND:3467

subject_name: gentamicin


subject: PUBCHEM.COMPOUND:3467


subject: PUBCHEM.COMPOUND:3467


subject: PUBCHEM.COMPOUND:284240

object_name: Anatomic Stage IIB Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:284240

object_name: Prognostic Stage IIB Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:284240

object_name: Stage IIB Breast Carcinoma


subject: PUBCHEM.COMPOUND:284240

object_name: malignant neoplasm of breast stage IIb


subject: PUBCHEM.COMPOUND:284240

object_name: Stage IIIC Breast Cancer AJCC v6


subject: PUBCHEM.COMPOUND:284240

object_name: Stage IIIC Breast Cancer AJCC v7


subject: PUBCHEM.COMPOUND:284240

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:284240

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:284240

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:284240

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:284240

object_name: Stage IIIA Breast Carcinoma


subject: PUBCHEM.COMPOUND:284240

object_name: Stage IIIB Breast Carcinoma


subject: PUBCHEM.COMPOUND:284240

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:284240

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: UNII:2X1K91UT6N

subject_name: Alovudine F-18


subject: UNII:2X1K91UT6N


subject: UNII:2X1K91UT6N


subject: UNII:2X1K91UT6N


subject: UNII:2X1K91UT6N


subject: UNII:2X1K91UT6N


subject: UNII:2X1K91UT6N


subject: UNII:2X1K91UT6N


subject: UNII:2X1K91UT6N


subject: UNII:2X1K91UT6N


subject: UNII:2X1K91UT6N


subject: UNII:2X1K91UT6N


subject: UNII:2X1K91UT6N


subject: UNII:2X1K91UT6N


subject: CHEBI:147281


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: metabolic dysfunction-associated steatotic liver disease


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: MESH:C000712032

subject_name: q-griffithsin


subject: UNII:911T37M2WY

object_name: tuberculosis


subject: PUBCHEM.COMPOUND:58008990

subject_name: Duvelisib

object_name: Indolent Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:58008990

object_name: Indolent Adult Non-Hodgkin Lymphoma


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: congenital heart disease


subject: CHEBI:41879

object_name: carcinoma of esophagus


subject: CHEBI:41879

object_name: esophageal cancer


subject: CHEBI:41879

object_name: Childhood Esophageal Carcinoma


subject: CHEBI:41879

object_name: neoplasm of esophagus


subject: CHEBI:32759

subject_name: L-tyrosinyl

object_name: High grade glioma


subject: CHEBI:32759

object_name: malignant glioma


subject: CHEBI:46858

subject_name: L-tyrosine residue


subject: CHEBI:46858


subject: CHEBI:17895

subject_name: Tyrosine


subject: CHEBI:17895


subject: UNII:1326R5J1IA

subject_name: FET F-18


subject: UNII:1326R5J1IA


subject: UMLS:C1831729


subject: UMLS:C1831729


subject: CHEBI:131701

subject_name: poly(ethylene terephthalate)(1-)


subject: CHEBI:131701


subject: UMLS:C5191484

subject_name: Polyethylene glycol only product in oral dose form

object_name: opioid-induced constipation


subject: CHEBI:9168

subject_name: Sirolimus

object_name: hypertension


subject: CHEBI:9168

object_name: Hypertension, CTCAE


subject: CHEBI:506227

subject_name: N-acetyl-D-glucosamine

object_name: Crohn disease


subject: CHEBI:28009

subject_name: N-Acetylglucosamine


subject: CHEBI:59640

subject_name: N-acetylglucosamine


subject: CHEBI:73685


subject: UMLS:C3854325

subject_name: Janus kinase inhibitor

object_name: adult dermatomyositis


subject: UNII:7K28NB895L

subject_name: Belzutifan

object_name: cancer


subject: GTOPDB:8691

subject_name: begelomab

object_name: graft versus host disease


subject: UNII:360N6PY2A1

subject_name: BEGELOMAB


subject: UMLS:C4059170

subject_name: Begelomab


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: Lower limb spasticity


subject: GTOPDB:12848

object_name: Refractory acute myeloid leukemia


subject: UMLS:C5555591

subject_name: netrin-1 inhibitor NP137


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: chronic obstructive pulmonary disease


subject: CHEBI:15698

subject_name: Deoxycytidine

object_name: skin melanoma


subject: CHEBI:15698

object_name: ocular melanoma


subject: CHEBI:15698

object_name: uveal melanoma


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: UMLS:C0354604

subject_name: oral anticoagulants

object_name: Ischemic stroke


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: Metastatic transitional cell carcinoma


subject: UMLS:C5418009

subject_name: BRAF Inhibitor BGB-3245

object_name: Childhood Solid Neoplasm


subject: UMLS:C5418009

object_name: Adult Solid Neoplasm


subject: UMLS:C5418009

object_name: Solid Neoplasm


subject: UMLS:C5418009

object_name: BRAF mutation-related tumors


subject: PUBCHEM.COMPOUND:155543961

subject_name: LIRAGLUTIDE

object_name: Acute Heart Failure Related to COVID-19


subject: PUBCHEM.COMPOUND:155543961

object_name: Acute heart failure


subject: UMLS:C1099192


subject: UMLS:C1099192


subject: UMLS:C4688609

subject_name: SEL 110

object_name: gout


subject: UMLS:C5814625


subject: CHEBI:3770

subject_name: co-trimoxazole

object_name: end stage renal failure


subject: CHEBI:3770

object_name: Chronic uremia


subject: CHEBI:9332

subject_name: Sulfamethoxazole


subject: CHEBI:9332


subject: RXCUI:151399

subject_name: Bactrim


subject: RXCUI:151399


subject: CHEBI:465284

subject_name: Ganciclovir


subject: CHEBI:465284


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:9168

subject_name: Sirolimus


subject: CHEBI:195557

object_name: heparin-induced thrombocytopenia


subject: CHEBI:195557

object_name: autoimmune thrombocytopenic purpura


subject: UMLS:C0359156

subject_name: Thymoglobulin

object_name: immunodeficiency disease


subject: UMLS:C0359156

object_name: Thymic aplasia


subject: CHEBI:201431

subject_name: Cyclosporin H


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:240107

subject_name: Bromfenac

object_name: diabetic macular edema


subject: CHEBI:71956

subject_name: retaspimycin hydrochloride


subject: CHEBI:93755


subject: UMLS:C1708447

subject_name: IPI 504


subject: CHEBI:28918

subject_name: Epinephrine

object_name: Cardiac Arrest, CTCAE


subject: UMLS:C0795577

subject_name: recombinant antihemophilic factor VIII

object_name: hereditary von Willebrand disease


subject: UMLS:C0795577

object_name: von Willebrand disease (hereditary or acquired)


subject: UNII:5PKM8P0G5I

subject_name: Vonicog alfa


subject: UMLS:C4282769

subject_name: VON WILLEBRAND FACTOR,RECOMBINANT


subject: UMLS:C1455750

subject_name: Triticum aestivum antigen

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UMLS:C1455750

object_name: obesity


subject: UMLS:C1455750

object_name: Obesity, CTCAE


subject: UMLS:C1455750

object_name: Insulin Sensitivity


subject: UMLS:C1455750

object_name: Drug action (disorder)


subject: PR:000015494

subject_name: spermatogenesis-associated protein 6

object_name: alcohol impairment


subject: UniProtKB:Q99MU5

subject_name: SPAT6_RAT Spermatogenesis-associated protein 6 (sprot)


subject: CHEBI:66964

subject_name: Dronabinol


subject: UMLS:C0907160

subject_name: Pegylated Interferon Alfa

object_name: renal carcinoma


subject: UMLS:C0907160

object_name: kidney neoplasm


subject: UMLS:C0907160

object_name: kidney cancer


subject: UNII:H5212R2DPM

object_name: pancreatic neoplasm


subject: UNII:H5212R2DPM

object_name: exocrine pancreatic carcinoma


subject: UNII:H5212R2DPM

object_name: malignant pancreatic neoplasm


subject: DRUGBANK:DB19210


subject: DRUGBANK:DB19210


subject: DRUGBANK:DB19210


subject: CHEBI:8988

object_name: Childhood Malignant Solid Neoplasm


subject: CHEBI:8988

object_name: Malignant Solid Neoplasm


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:80630


subject: UNII:7RPW6SU9SC

object_name: Advanced cancer


subject: UNII:7RPW6SU9SC

object_name: Disseminated Malignant Neoplasm


subject: UNII:7RPW6SU9SC

object_name: Embolism, Tumor


subject: UNII:7RPW6SU9SC

object_name: Neoplasm Metastasis


subject: UNII:C3VX249T6L

subject_name: Ravulizumab

object_name: acute respiratory distress syndrome


subject: UNII:C3VX249T6L

object_name: acute lung injury


subject: UNII:C3VX249T6L

object_name: adult acute respiratory distress syndrome


subject: UNII:C3VX249T6L

object_name: viral pneumonia


subject: UMLS:C4086207


subject: UMLS:C4086207


subject: UMLS:C4086207


subject: UMLS:C4086207


subject: PUBCHEM.COMPOUND:146262473

subject_name: Linvemastat

object_name: Pulmonary function (finding)


subject: PUBCHEM.COMPOUND:146262473

object_name: asthma


subject: UNII:FP2AMM4SVF

subject_name: LINVEMASTAT


subject: UNII:FP2AMM4SVF


subject: UMLS:C4305687

object_name: myocardial ischemia


subject: UMLS:C4305687

object_name: coronary atherosclerosis


subject: UMLS:C4305687

object_name: Reperfusion Injury


subject: CHEBI:18405

subject_name: Pyridoxal phosphate


subject: CHEBI:18405


subject: CHEBI:18405


subject: MESH:C477385

subject_name: montanide ISA 51

object_name: Malaria, Vivax


subject: CHEBI:192614

subject_name: Homosildenafil

object_name: congenital diaphragmatic hernia


subject: CHEBI:192614

object_name: hiatus hernia


subject: CHEBI:192614

object_name: pulmonary hypoplasia


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: UNII:L6WO34R9YG


subject: UNII:L6WO34R9YG


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: PUBCHEM.COMPOUND:131769997


subject: PUBCHEM.COMPOUND:131769997


subject: CHEBI:183660

subject_name: Acetildenafil


subject: CHEBI:183660


subject: CHEBI:183660


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: UNII:80X7B1F6NW


subject: UNII:80X7B1F6NW


subject: CHEBI:9139

subject_name: Sildenafil


subject: CHEBI:9139


subject: CHEBI:9139


subject: CHEBI:8499

subject_name: Propranolol

object_name: Surgical procedure finding


subject: CHEBI:8499

object_name: pancreatic neoplasm


subject: CHEBI:8499

object_name: exocrine pancreatic carcinoma


subject: CHEBI:8499

object_name: malignant pancreatic neoplasm


subject: UMLS:C0016004

subject_name: Beriplast P


subject: UMLS:C1832057

subject_name: TISSEEL VH


subject: UMLS:C1832057

object_name: Childhood Breast Carcinoma


subject: UMLS:C1832057

object_name: breast carcinoma


subject: UMLS:C1832057

object_name: breast cancer


subject: UMLS:C0003442

subject_name: lymphocyte immune globulin, anti-thymocyte globulin

object_name: Solid Neoplasm


subject: UMLS:C5418001

subject_name: LAIR-2 Fusion Protein NC410


subject: UMLS:C5418001


subject: UMLS:C5418001


subject: CHEBI:15765

subject_name: Levodopa

object_name: dyslexia


subject: PUBCHEM.COMPOUND:9852982

subject_name: Ceftaroline

object_name: cystic fibrosis


subject: PUBCHEM.COMPOUND:72562361

subject_name: Ceftaroline fosamil


subject: CHEBI:35553

subject_name: Perhexiline

object_name: Left ventricular hypertrophy


subject: UMLS:C5959293

subject_name: SIRP-alpha-Fc Fusion Protein HCB101

object_name: Non-Hodgkin's lymphoma refractory


subject: UMLS:C5959293

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:50693

subject_name: Milrinone

object_name: heart failure


subject: CHEBI:50693

object_name: Heart Failure, CTCAE


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Heartburn


subject: CHEBI:73604

object_name: esophageal atresia


subject: CHEBI:73604

object_name: congenital diaphragmatic hernia


subject: CHEBI:73604

object_name: hiatus hernia


subject: PUBCHEM.COMPOUND:4715169

subject_name: 3-(Aminomethyl)-5-methylhexanoic acid

object_name: spinal stenosis


subject: PUBCHEM.COMPOUND:4715169

object_name: Failed Back Surgery Syndrome


subject: PUBCHEM.COMPOUND:4715169

object_name: Epiphysiolysis


subject: PUBCHEM.COMPOUND:4715169

object_name: neuropathy; radicular, lumbar, lumbosacral


subject: CHEBI:64356

subject_name: Pregabalin


subject: CHEBI:64356


subject: CHEBI:64356


subject: UNII:3XVL385Q0M

subject_name: Filgotinib

object_name: juvenile idiopathic arthritis


subject: CHEBI:9943

subject_name: Venlafaxine

object_name: body dysmorphic disorder


subject: UNII:I5I8VB78VT

subject_name: Erenumab

object_name: fibromyalgia


subject: CHEBI:91899

object_name: Exercise-induced asthma


subject: CHEBI:3207

subject_name: Budesonide


subject: CHEBI:5147

subject_name: Formoterol


subject: CHEBI:408174

subject_name: Arformoterol


subject: CHEBI:9449

subject_name: Terbutaline

object_name: asthma


subject: CHEBI:9449


subject: CHEBI:7824

subject_name: Oxcarbazepine

object_name: pervasive developmental disorder


subject: CHEBI:7824

object_name: autism


subject: CHEBI:16664

subject_name: Albendazole

object_name: Infection


subject: CHEBI:16664

object_name: infectious disease


subject: CHEBI:16664

object_name: Adverse Event Associated with Infection


subject: CHEBI:8654

subject_name: Pyrantel

object_name: malnutrition


subject: CHEBI:8654


subject: CHEBI:8654


subject: CHEBI:8654


subject: UMLS:C1508746

subject_name: egg extract


subject: UMLS:C1508746


subject: UMLS:C1508746


subject: UMLS:C1508746


subject: DRUGBANK:DB10529

subject_name: Egg


subject: DRUGBANK:DB10529


subject: DRUGBANK:DB10529


subject: DRUGBANK:DB10529


subject: UMLS:C1446647

subject_name: Milk antigen


subject: UMLS:C1446647


subject: UMLS:C1446647


subject: UMLS:C1446647


subject: DRUGBANK:DB10543

subject_name: Cow milk


subject: DRUGBANK:DB10543


subject: DRUGBANK:DB10543


subject: DRUGBANK:DB10543


subject: UMLS:C0444318

subject_name: Milk Specimen


subject: UMLS:C0444318


subject: UMLS:C0444318


subject: UMLS:C0444318


subject: CHEBI:66910

subject_name: Axitinib

object_name: alveolar soft part sarcoma


subject: CHEBI:144903

subject_name: Pro-Arg-Pro

object_name: acne


subject: CHEBI:61848


subject: PR:000013192


subject: UniProtKB:P05142

subject_name: PRH1_MOUSE Proline-rich protein HaeIII subfamily 1 (sprot)


subject: PR:000013551


subject: PR:000003551

subject_name: ATP-binding cassette sub-family B member 6


subject: UniProtKB:P67986

subject_name: PRIO_CEREN Major prion protein (sprot)


subject: PR:000001886

subject_name: major prion protein


subject: PR:000030465

subject_name: C4b-binding protein alpha chain


subject: PR:000013555

subject_name: proline-rich protein 2


subject: UniProtKB:P05143

subject_name: PRP2_MOUSE Proline-rich protein 2 (sprot)


subject: PR:000032963

subject_name: proline-rich protein HaeIII subfamily 1


subject: CHEBI:28429

subject_name: ampelopsin

object_name: type 2 diabetes mellitus


subject: PUBCHEM.COMPOUND:131752975

subject_name: Ampelopsin D


subject: CHEBI:28917

subject_name: dihydromyricetin


subject: CHEBI:68554

subject_name: Deferiprone

object_name: hemochromatosis


subject: CHEBI:68554

object_name: hemosiderosis


subject: CHEBI:68554

object_name: hemochromatosis type 1


subject: UMLS:C0600472

subject_name: Long Interspersed Nucleotide Element-1


subject: UMLS:C0600472


subject: UMLS:C0600472


subject: UniProtKB:P03101

subject_name: VL1_HPV16 Major capsid protein L1 (sprot)


subject: UniProtKB:P03101


subject: UniProtKB:P03101


subject: UniProtKB:Q07860

subject_name: VL1_HPV04 Major capsid protein L1 (sprot)


subject: UniProtKB:Q07860


subject: UniProtKB:Q07860


subject: PR:000029475

subject_name: CYFIP-related Rac1 interactor B


subject: PR:000029475


subject: PR:000029475


subject: CHEBI:4856

subject_name: Esmolol

object_name: Nociceptive Pain


subject: CHEBI:4856

object_name: Opioid use, unspecified


subject: CHEBI:27470

subject_name: Folic acid

object_name: carcinoma of esophagus


subject: CHEBI:27470

object_name: esophageal cancer


subject: CHEBI:27470

object_name: Childhood Esophageal Carcinoma


subject: CHEBI:27470

object_name: neoplasm of esophagus


subject: GTOPDB:13792

subject_name: iparomlimab


subject: UNII:FN3VWV28BC

subject_name: IPAROMLIMAB


subject: UMLS:C5669553

subject_name: Iparomlimab


subject: GTOPDB:13793

subject_name: tuvonralimab


subject: UNII:8XWO7LI4LO

subject_name: TUVONRALIMAB


subject: UMLS:C5784793

subject_name: Tuvonralimab


subject: CHEBI:30884

subject_name: glycoloyl group


subject: CHEBI:73890

subject_name: Gly-Cys


subject: UMLS:C0678449

subject_name: Cannabis substance

object_name: Cannabis use


subject: UMLS:C0678449

object_name: Tobacco user


subject: UMLS:C0678449

object_name: Tobacco use history


subject: UMLS:C0678449

object_name: Encounter due to tobacco use


subject: UMLS:C0678449

object_name: Electronic cigarette exposure history


subject: UMLS:C0024808

subject_name: Marihuana


subject: UMLS:C0024808


subject: UMLS:C0024808


subject: UMLS:C0024808


subject: UMLS:C0024808


subject: UMLS:C4552088

subject_name: Cannabis sativa whole extract


subject: UMLS:C4552088


subject: UMLS:C4552088


subject: UMLS:C4552088


subject: UMLS:C4552088


subject: CHEBI:17688

subject_name: Nicotine


subject: CHEBI:17688

object_name: thrombocytopenia 1


subject: CHEBI:17688


subject: CHEBI:6149

subject_name: Levobupivacaine

object_name: brain neoplasm


subject: UMLS:C0681579

subject_name: Vitamin supplement

object_name: type 2 diabetes mellitus


subject: UNII:6FHZ595FNM

object_name: chronic kidney disease


subject: UNII:6FHZ595FNM

object_name: Chronic Kidney Disease, CTCAE


subject: UMLS:C0721124

subject_name: Iron Supplement

object_name: anemia


subject: UMLS:C0721124

object_name: Anemia, CTCAE


subject: UMLS:C2825025

subject_name: Iron Supplement [EPC]


subject: UMLS:C2825025


subject: UMLS:C5777300

subject_name: Iron Drops


subject: UMLS:C5777300


subject: UNII:37CQ2C7X93

subject_name: Canakinumab

object_name: vascular inflammations


subject: UNII:37CQ2C7X93

object_name: cardiovascular disorder


subject: UNII:37CQ2C7X93

object_name: arteriosclerosis disorder


subject: UNII:37CQ2C7X93

object_name: atherosclerosis


subject: UMLS:C2718754

subject_name: Ilaris


subject: UMLS:C2718754


subject: GTOPDB:13396

subject_name: ivonescimab

object_name: Stage II Renal Cell Cancer AJCC v8


subject: GTOPDB:13396

object_name: Resectable Clear Cell Renal Cell Carcinoma


subject: GTOPDB:13396

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: GTOPDB:13396

object_name: Stage III Renal Cell Cancer AJCC v8


subject: UNII:Y0O332CU66

subject_name: IVONESCIMAB


subject: UNII:Y0O332CU66


subject: UNII:Y0O332CU66


subject: UNII:Y0O332CU66


subject: UMLS:C5669600

subject_name: Ivonescimab


subject: UMLS:C5669600


subject: UMLS:C5669600


subject: UMLS:C5669600


subject: CHEBI:23965

subject_name: estradiol


subject: CHEBI:23965


subject: PUBCHEM.COMPOUND:53477739

subject_name: Vasopressin

object_name: hypotension


subject: PUBCHEM.COMPOUND:53477739

object_name: Hypotension, CTCAE


subject: PUBCHEM.COMPOUND:11979316


subject: PUBCHEM.COMPOUND:11979316


subject: UMLS:C5966161

subject_name: Vasopressin (anatomical)


subject: UMLS:C5966161


subject: UMLS:C5397366

subject_name: Influenza A virus subtype H1N1 antigen only vaccine product

object_name: influenza


subject: PUBCHEM.COMPOUND:21151177

object_name: prostate cancer


subject: MESH:C000722752

subject_name: mRNA-1273.214 COVID-19 vaccine


subject: MESH:C000722752

object_name: respiratory syncytial virus infectious disease


subject: DRUGBANK:DB18739


subject: CHEBI:50730

subject_name: Montelukast

object_name: persian gulf syndrome


subject: PUBCHEM.COMPOUND:70693549

subject_name: SUGAMMADEX SODIUM

object_name: obstructive sleep apnea syndrome


subject: PUBCHEM.COMPOUND:74030550

subject_name: Sugammadex


subject: CHEBI:601027

subject_name: Aliskiren

object_name: Ankle swelling


subject: CHEBI:2668

subject_name: Amlodipine


subject: CHEBI:94366

subject_name: itraconazole

object_name: Medulloblastoma, Not Otherwise Specified


subject: CHEBI:8107

subject_name: Phenytoin


subject: CHEMBL.COMPOUND:CHEMBL5314951

subject_name: SONROTOCLAX


subject: UNII:30R67U9KYS


subject: PUBCHEM.COMPOUND:135565889

subject_name: Etarfolatide

object_name: lung adenocarcinoma


subject: CHEBI:134736

subject_name: Vintafolide


subject: CHEBI:173106

subject_name: ferroptocide

object_name: outcomes general quality of life


subject: CHEBI:173106

object_name: Perceived quality of life


subject: CHEBI:173106

object_name: Good quality of life


subject: CHEBI:173106

object_name: Cognitive impairment


subject: CHEBI:173106

object_name: Poor quality sleep


subject: CHEBI:31536

subject_name: Emtricitabine


subject: CHEBI:31536


subject: CHEBI:31536


subject: CHEBI:31536


subject: PUBCHEM.COMPOUND:90465822

subject_name: Ferric pyrophosphate, soluble

object_name: RENAL FAILURE CHRONIC REQUIRING HEMODIALYSIS


subject: CHEBI:23812

subject_name: dimethylmaleic acid


subject: CHEBI:132767

subject_name: Ferric pyrophosphate


subject: UMLS:C0075029

subject_name: spleen fibrinolytic proteinase (human)


subject: CHEBI:48923

subject_name: erythromycin

object_name: Gastrointestinal hemorrhage


subject: CHEBI:48923

object_name: Hematemesis


subject: CHEBI:42355

subject_name: Erythromycin


subject: CHEBI:42355


subject: UNII:D86MF5H9WJ

subject_name: Cemsidomide

object_name: non-Hodgkin lymphoma


subject: CHEBI:9927

subject_name: Valsartan

object_name: arteriosclerosis disorder


subject: CHEBI:9927

object_name: atherosclerosis


subject: CHEBI:9927

object_name: carotid artery disorder


subject: PUBCHEM.COMPOUND:54675783

subject_name: minocycline

object_name: atrial fibrillation


subject: PUBCHEM.COMPOUND:54675783

object_name: Atrial Fibrillation by ECG Finding


subject: PUBCHEM.COMPOUND:54675783

object_name: Atrial Fibrillation, CTCAE


subject: PUBCHEM.COMPOUND:6320532

subject_name: Cenicriviroc

object_name: HIV-1 infection


subject: UMLS:C3252224

subject_name: TBR 652


subject: CHEMBL.COMPOUND:CHEMBL2109619

object_name: influenza


subject: UNII:A3ULP0F556

subject_name: Eculizumab

object_name: dense deposit disease


subject: UNII:A3ULP0F556


subject: DRUGBANK:DB17916

object_name: cystic fibrosis


subject: DRUGBANK:DB17916

object_name: bronchiectasis


subject: UMLS:C0134223

subject_name: OSCN-


subject: UMLS:C0134223


subject: UMLS:C1250042

subject_name: oxytocin nasal spray

object_name: Prader-Willi syndrome


subject: GTOPDB:9311

subject_name: urelumab

object_name: leukemia


subject: GTOPDB:9311

object_name: childhood leukemia


subject: CHEMBL.COMPOUND:CHEMBL1743085

subject_name: URELUMAB


subject: CHEMBL.COMPOUND:CHEMBL1743085


subject: UMLS:C1831875


subject: UMLS:C1831875


subject: CHEBI:4757

object_name: kidney disorder


subject: CHEBI:4757

object_name: Chronic uremia


subject: UNII:99J2XUF1JT

subject_name: Gd-Dota


subject: UNII:99J2XUF1JT


subject: CHEBI:73735

subject_name: gadoterate


subject: CHEBI:73735


subject: PUBCHEM.COMPOUND:3085828

subject_name: Gadoteric acid


subject: PUBCHEM.COMPOUND:3085828


subject: CHEBI:28918

subject_name: Epinephrine

object_name: Intraoperative blood loss


subject: CHEBI:194548

subject_name: Racepinephrine


subject: MESH:C495817

object_name: malignant glioma


subject: MESH:C495817

object_name: glioblastoma


subject: MESH:C495817

object_name: Childhood Glioblastoma


subject: MESH:C495817

object_name: adult glioblastoma


subject: UNII:98BSN6N516

subject_name: Rogaratinib

object_name: Carcinoma breast stage IV


subject: UNII:98BSN6N516

object_name: Hormone receptor positive malignant neoplasm of breast


subject: CHEBI:91951


subject: PUBCHEM.COMPOUND:17756771

subject_name: Fulvestrant


subject: UMLS:C4053607

object_name: Non-small cell lung cancer stage III


subject: CHEBI:17154

subject_name: Nicotinamide

object_name: skin neoplasm


subject: CHEBI:17154

object_name: skin cancer


subject: CHEBI:16302


subject: CHEBI:16302


subject: UNII:81G40H8B0T

subject_name: VITAMIN A


subject: UNII:81G40H8B0T


subject: UMLS:C3714656

subject_name: Vitamin A Drug Class


subject: UMLS:C3714656


subject: CHEBI:12777

subject_name: Vitamin A


subject: CHEBI:12777


subject: UMLS:C2825076

subject_name: Vitamin A [EPC]


subject: UMLS:C2825076


subject: PUBCHEM.COMPOUND:9995208

subject_name: Estetrol

object_name: breast neoplasm


subject: RXCUI:1999664

subject_name: bictegravir / emtricitabine / tenofovir alafenamide Oral Product

object_name: Adherence To Medication Regime


subject: UNII:68AYS9A614

subject_name: CEDIRANIB MALEATE

object_name: Mesothelioma malignant localised


subject: UMLS:C2711999

subject_name: cediranib maleate


subject: UMLS:C0812735

subject_name: INJECTION FLUCONAZOLE, 200 MG ADMINISTERED

object_name: inflammatory bowel disease


subject: CHEBI:46081

subject_name: Fluconazole


subject: UMLS:C0963149

subject_name: Definity

object_name: Alzheimer disease type 1


subject: UMLS:C0963149

object_name: Alzheimer disease


subject: CHEBI:31980

subject_name: Perflutren


subject: CHEBI:31980


subject: CHEBI:52717

subject_name: Bortezomib

object_name: sickle cell disease


subject: CHEBI:52717

object_name: thalassemia


subject: CHEBI:52717

object_name: beta thalassemia


subject: CHEBI:52717

object_name: beta-thalassemia HBB/LCRB


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:41879


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:168396


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:8764


subject: UMLS:C0359156

subject_name: Thymoglobulin


subject: UMLS:C0359156


subject: UMLS:C0359156


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: CHEBI:61057


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: DRUGBANK:DB05427

object_name: skin melanoma


subject: PUBCHEM.COMPOUND:3086655

subject_name: Tiotropium

object_name: bronchiolitis obliterans syndrome


subject: PUBCHEM.COMPOUND:11431811

subject_name: Tiotropium Bromide Monohydrate


subject: CHEBI:60799

subject_name: Esketamine

object_name: Atopic rhinitis


subject: CHEBI:60799

object_name: Allergic Rhinitis, CTCAE


subject: CHEBI:6970

subject_name: Mometasone


subject: UMLS:C0879396

object_name: non-small cell lung carcinoma


subject: CHEBI:10033

subject_name: Warfarin

object_name: pulmonary hypertension, primary, 1


subject: CHEBI:10033

object_name: pulmonary hypertension


subject: CHEBI:10033

object_name: idiopathic pulmonary arterial hypertension


subject: CHEBI:10033

object_name: pulmonary arterial hypertension


subject: CHEMBL.COMPOUND:CHEMBL4297564

subject_name: COBITOLIMOD

object_name: ulcerative colitis


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: Post-Dural Puncture Headaches


subject: CHEBI:94573

subject_name: Zibotentan

object_name: Embolism, Tumor


subject: CHEBI:94573

object_name: Neoplasm Metastasis


subject: CHEBI:94573

object_name: Metastasis


subject: CHEBI:94573

object_name: Metastatic Lesion


subject: UMLS:C2744646

object_name: Pancreatic adenocarcinoma metastatic


subject: UMLS:C2830125


subject: CHEBI:145371

subject_name: Binimetinib


subject: CHEBI:32090

subject_name: Rebamipide

object_name: dyspepsia


subject: CHEBI:32090

object_name: Dyspepsia, CTCAE


subject: CHEBI:32090

object_name: chronic gastritis


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: Her2-receptor negative breast cancer


subject: PUBCHEM.COMPOUND:2767

object_name: male breast carcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:2767

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: estrogen receptor-negative breast cancer


subject: PUBCHEM.COMPOUND:2767

object_name: progesterone receptor-negative breast cancer


subject: PUBCHEM.COMPOUND:2767

object_name: hereditary breast/ovarian cancer - BRCA2


subject: PUBCHEM.COMPOUND:2767

object_name: hereditary breast/ovarian cancer - BRCA1


subject: CHEBI:62880

subject_name: Veliparib


subject: CHEBI:62880


subject: CHEBI:62880


subject: CHEBI:62880


subject: CHEBI:62880


subject: CHEBI:62880


subject: CHEBI:32296

subject_name: vinorelbine L-tartrate


subject: CHEBI:32296

object_name: Breast cancer recurrent


subject: CHEBI:32296


subject: CHEBI:32296

object_name: triple-negative breast carcinoma


subject: CHEBI:32296

object_name: Triple-Negative Breast Cancer Finding


subject: CHEBI:32296


subject: CHEBI:32296

object_name: Carcinoma breast stage IV


subject: CHEBI:32296


subject: CHEBI:32296


subject: CHEBI:32296


subject: CHEBI:32296


subject: PUBCHEM.COMPOUND:16051941


subject: PUBCHEM.COMPOUND:16051941


subject: PUBCHEM.COMPOUND:16051941


subject: PUBCHEM.COMPOUND:16051941


subject: PUBCHEM.COMPOUND:16051941


subject: PUBCHEM.COMPOUND:16051941


subject: PUBCHEM.COMPOUND:16051941


subject: PUBCHEM.COMPOUND:16051941


subject: PUBCHEM.COMPOUND:16051941


subject: PUBCHEM.COMPOUND:16051941


subject: PUBCHEM.COMPOUND:16051941


subject: CHEBI:53750

subject_name: vinorelbine D-tartrate


subject: CHEBI:53750


subject: CHEBI:53750


subject: CHEBI:53750


subject: CHEBI:53750


subject: CHEBI:53750


subject: CHEBI:53750


subject: CHEBI:53750


subject: CHEBI:53750


subject: CHEBI:53750


subject: CHEBI:53750


subject: PUBCHEM.COMPOUND:44424639

subject_name: Vinorelbine


subject: PUBCHEM.COMPOUND:44424639


subject: PUBCHEM.COMPOUND:44424639


subject: PUBCHEM.COMPOUND:44424639


subject: PUBCHEM.COMPOUND:44424639


subject: PUBCHEM.COMPOUND:44424639


subject: PUBCHEM.COMPOUND:44424639


subject: PUBCHEM.COMPOUND:44424639


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEMBL.COMPOUND:CHEMBL2108424

subject_name: MAGNESIUM GLYCINATE

object_name: colorectal cancer


subject: CHEMBL.COMPOUND:CHEMBL2108424

object_name: colorectal carcinoma


subject: CHEMBL.COMPOUND:CHEMBL2108424

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UNII:IFN18A4Y6B

subject_name: Magnesium glycinate


subject: UNII:IFN18A4Y6B


subject: UNII:IFN18A4Y6B


subject: CHEBI:40968

subject_name: Astaxanthin

object_name: Onychomalacia


subject: CHEBI:40968

object_name: alopecia


subject: CHEBI:40968

object_name: cutis laxa


subject: CHEBI:40968

object_name: Acne cosmetica


subject: CHEBI:17761

subject_name: ceramide


subject: CHEBI:17761


subject: CHEBI:17761


subject: CHEBI:17761


subject: UMLS:C0010803

subject_name: Cytokeratin


subject: UMLS:C0010803


subject: UMLS:C0010803


subject: UMLS:C0022564

subject_name: Keratin


subject: UMLS:C0022564


subject: UMLS:C0022564


subject: UMLS:C0042210

subject_name: Vaccines

object_name: gonorrhea


subject: UMLS:C5399710

subject_name: Vaccine [APC]


subject: PR:000002082

subject_name: receptor tyrosine-protein kinase erbB-2

object_name: malignant glioma


subject: PR:000002082

object_name: Recurrent Glioma


subject: PR:000002082

object_name: Refractory Glioma


subject: PR:000002082

object_name: grade III glioma


subject: PR:000002082

object_name: glioblastoma


subject: PR:000002082

object_name: Childhood Glioblastoma


subject: PR:000002082

object_name: adult glioblastoma


subject: UMLS:C0069515

subject_name: erbB-2 Receptor


subject: UMLS:C0069515


subject: UMLS:C0069515


subject: UMLS:C0069515


subject: UMLS:C0069515


subject: UMLS:C0069515


subject: UMLS:C0069515


subject: CHEBI:77323

subject_name: Ethoxyquin


subject: CHEBI:77323


subject: CHEBI:77323


subject: CHEBI:77323


subject: CHEBI:77323


subject: CHEBI:77323


subject: CHEBI:77323


subject: CHEBI:141435

subject_name: Glu-Gln


subject: CHEBI:141435


subject: CHEBI:141435


subject: CHEBI:141435


subject: CHEBI:141435


subject: CHEBI:141435


subject: CHEBI:141435


subject: UMLS:C5417999

subject_name: Anti-5T4 Antibody-drug Conjugate ASN004

object_name: Childhood Solid Neoplasm


subject: UMLS:C5417999

object_name: Adult Solid Neoplasm


subject: UMLS:C5417999

object_name: Solid Neoplasm


subject: CHEBI:177425

subject_name: Patidegib

object_name: basal cell carcinoma


subject: CHEBI:177425

object_name: bone chondrosarcoma


subject: CHEBI:177425

object_name: chondrosarcoma


subject: UMLS:C5416852

subject_name: Sputnik V


subject: UMLS:C5416852

object_name: Vaccine adverse reaction


subject: UMLS:C5400622

subject_name: Gam-COVID-Vac


subject: CHEBI:229902

subject_name: Serlopitant

object_name: Pruritus, CTCAE


subject: CHEBI:229902

object_name: Pruritus


subject: CHEBI:229902

object_name: Burn injury


subject: UNII:L65E7T81M5

subject_name: DULANERMIN

object_name: non-Hodgkin lymphoma


subject: UMLS:C1522480

subject_name: AMG 951


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: chronic kidney disease


subject: CHEBI:8404

subject_name: Prilocaine


subject: UNII:6M27443B0N

subject_name: MILADEMETAN TOSYLATE

object_name: acute myeloid leukemia by FAB classification


subject: UNII:6M27443B0N

object_name: acute myeloid leukemia


subject: UNII:6M27443B0N

object_name: Refractory acute myeloid leukemia


subject: UNII:6M27443B0N

object_name: Recurrent Acute Myeloid Leukemia


subject: UMLS:C4724797

subject_name: Milademetan Tosylate


subject: UMLS:C4724797


subject: UMLS:C4724797


subject: UMLS:C4724797


subject: UNII:51JV4753AD

object_name: Alzheimer disease type 1


subject: UNII:51JV4753AD

object_name: Alzheimer disease


subject: CHEBI:48538

subject_name: Apomorphine

object_name: brain injury


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: SARS-associated coronavirus as cause of disease classified elsewhere


subject: CHEBI:28939

object_name: SARS-CoV-2 acute respiratory disease


subject: CHEBI:28939

object_name: COVID-19 respiratory infection


subject: CHEBI:28939

object_name: Pneumonia caused by SARS-CoV-2


subject: UNII:P93RUU11P7

subject_name: INOTUZUMAB

object_name: diffuse large B-cell lymphoma


subject: UNII:3160WY51LV

subject_name: Bixalomer

object_name: end stage renal failure


subject: UNII:3160WY51LV

object_name: Chronic uremia


subject: UMLS:C0009906

subject_name: Combined Oral Contraceptives

object_name: disorder of bone development and growth


subject: CHEBI:6121

subject_name: Ketamine

object_name: heart disorder


subject: CHEBI:44915

subject_name: Propofol


subject: CHEBI:9130

subject_name: Sevoflurane


subject: CHEBI:15367

subject_name: Tretinoin

object_name: lymphoproliferative syndrome


subject: CHEBI:15367

object_name: HIV infection


subject: CHEBI:15367

object_name: immunodeficiency disease


subject: CHEBI:15367

object_name: inborn error of immunity


subject: UNII:38073MQB2A

subject_name: Umbralisib

object_name: Waldenstrom macroglobulinemia


subject: CHEBI:8378

subject_name: Prednisolone

object_name: Atopic rhinitis


subject: CHEBI:8378

object_name: Allergic Rhinitis, CTCAE


subject: CHEMBL.COMPOUND:CHEMBL2108929

subject_name: COTTONSEED OIL

object_name: Hypercholesterolemia


subject: CHEBI:35338

subject_name: amphetamines

object_name: attention deficit hyperactivity disorder, inattentive type


subject: CHEBI:35338


subject: UMLS:C1971782

subject_name: DEXTROAMPHETAMINE SULFATE, 5 MG ADMINISTERED


subject: UMLS:C1971782


subject: CHEBI:4469

subject_name: dexamfetamine


subject: CHEBI:4469


subject: CHEBI:9130

object_name: nephrogenic diabetes insipidus


subject: UMLS:C4722711

object_name: cancer


subject: UMLS:C4722711

object_name: neoplasm


subject: CHEBI:116735

subject_name: Benzocaine

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:116735

object_name: obesity


subject: CHEBI:116735

object_name: Obesity, CTCAE


subject: PUBCHEM.COMPOUND:18319735

subject_name: Mirabegron

object_name: Neurogenic detrusor overactivity


subject: CHEBI:31587

subject_name: Exatecan mesilate hydrate

object_name: malignant soft tissue neoplasm


subject: CHEBI:31587

object_name: sarcoma


subject: CHEBI:135709

subject_name: Exatecan


subject: CHEBI:135709


subject: UMLS:C0935945

subject_name: exatecan mesylate


subject: UMLS:C0935945


subject: UNII:8WE94VAO6U

subject_name: chiglitazar

object_name: Androgen excess


subject: CHEBI:81862

object_name: Encounter due to family history of osteoporosis


subject: CHEBI:81862

object_name: Osteoporosis, CTCAE 5.0


subject: CHEBI:81862

object_name: Osteoporosis, CTCAE 3.0


subject: CHEBI:81862

object_name: sarcopenia


subject: UMLS:C0812735

subject_name: INJECTION FLUCONAZOLE, 200 MG ADMINISTERED

object_name: Deep mycosis


subject: CHEBI:46081

subject_name: Fluconazole


subject: CHEBI:74707

subject_name: Met-Met

object_name: plasma cell myeloma


subject: CHEBI:53458


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: Neck Carcinoma


subject: UMLS:C1527137

object_name: head and neck neoplasm


subject: UMLS:C1527137

object_name: head and neck cancer


subject: CHEBI:16796

subject_name: Melatonin


subject: CHEBI:16796


subject: CHEBI:16796


subject: UMLS:C0733486

subject_name: Pre-Pen

object_name: penicillin allergy


subject: UMLS:C0733486

object_name: Allergy to penicillin


subject: UMLS:C1508862

subject_name: INJECTION, BEVACIZUMAB, 10 MG, Administered

object_name: cervical cancer


subject: UMLS:C1508862

object_name: cervical carcinoma


subject: UMLS:C1508862

object_name: rectal carcinoma


subject: UMLS:C1508862

object_name: rectal cancer


subject: UMLS:C1508862

object_name: Childhood Rectal Carcinoma


subject: UMLS:C1508862

object_name: ovarian cancer


subject: UMLS:C1508862

object_name: ovarian neoplasm


subject: UMLS:C1508862

object_name: ovarian carcinoma


subject: UMLS:C1508862

object_name: lung cancer


subject: UMLS:C1508862

object_name: lung neoplasm


subject: UMLS:C1508862

object_name: lung carcinoma


subject: UMLS:C1508862

object_name: glioblastoma


subject: UMLS:C1508862

object_name: Childhood Glioblastoma


subject: UMLS:C1508862

object_name: adult glioblastoma


subject: UMLS:C2729368

subject_name: INJECTION, BEVACIZUMAB, 0.25 MG, Administered


subject: UMLS:C2729368


subject: UMLS:C2729368


subject: UMLS:C2729368


subject: UMLS:C2729368


subject: UMLS:C2729368


subject: UMLS:C2729368


subject: UMLS:C2729368


subject: UMLS:C2729368


subject: UMLS:C2729368


subject: UMLS:C2729368


subject: UMLS:C2729368


subject: UMLS:C2729368


subject: UMLS:C2729368


subject: UMLS:C5203354

subject_name: Bevacizumab Liquid Injection


subject: UMLS:C5203354


subject: UMLS:C5203354


subject: UMLS:C5203354


subject: UMLS:C5203354


subject: UMLS:C5203354


subject: UMLS:C5203354


subject: UMLS:C5203354


subject: UMLS:C5203354


subject: UMLS:C5203354


subject: UMLS:C5203354


subject: UMLS:C5203354


subject: UMLS:C5203354


subject: UMLS:C5203354


subject: CHEBI:79699

subject_name: Temsirolimus

object_name: Advanced renal cell carcinoma


subject: UMLS:C0796512

subject_name: CCI 779


subject: CHEBI:5893

subject_name: Indapamide

object_name: type 2 diabetes mellitus


subject: UNII:37NT056AT4

subject_name: Remetinostat

object_name: skin basal cell carcinoma


subject: CHEBI:17895

subject_name: Tyrosine

object_name: fibromyalgia


subject: UNII:2UAV344O66

subject_name: Amonafide dihydrochloride

object_name: Childhood Breast Carcinoma


subject: UNII:2UAV344O66

object_name: breast carcinoma


subject: UNII:2UAV344O66

object_name: breast cancer


subject: UMLS:C1527333

subject_name: Amonafide Dihydrochloride


subject: UMLS:C1527333


subject: UMLS:C1527333


subject: CHEBI:167450

subject_name: Monomethyl fumarate

object_name: plasma cell myeloma


subject: UMLS:C3827153

object_name: prostate carcinoma


subject: CHEBI:6339

subject_name: Etoricoxib

object_name: Adverse anesthesia outcome


subject: DRUGBANK:DB14352

subject_name: Azadirachta indica leaf

object_name: Periapical abscess no sinus


subject: DRUGBANK:DB14352

object_name: suppurative periapical periodontitis


subject: DRUGBANK:DB17512

object_name: head and neck squamous cell carcinoma


subject: DRUGBANK:DB17512

object_name: HPV positive oropharyngeal squamous cell carcinoma


subject: CHEBI:51230

subject_name: Bimatoprost

object_name: generalized vitiligo


subject: CHEBI:151315

subject_name: Heparin

object_name: vulvodynia


subject: KEGG.COMPOUND:C00374


subject: RXCUI:659877

subject_name: Gardasil

object_name: Immunization reaction


subject: CHEBI:5001

subject_name: Fenofibrate

object_name: Klinefelter syndrome


subject: PUBCHEM.COMPOUND:6917991

subject_name: AeroVanc

object_name: cystic fibrosis


subject: UMLS:C2986391

subject_name: Anti-CD20 Monoclonal Antibody TL011

object_name: rheumatoid arthritis


subject: PUBCHEM.COMPOUND:75988815

subject_name: Elafibranor

object_name: Drug Interactions


subject: UMLS:C0021741

subject_name: Actimmune

object_name: primary peritoneal carcinoma


subject: UMLS:C0021741

object_name: Primary Peritoneal Cancer


subject: UMLS:C0021741

object_name: ovarian cancer


subject: UMLS:C0021741

object_name: ovarian neoplasm


subject: UMLS:C0021741

object_name: ovarian carcinoma


subject: UMLS:C0021741

object_name: fallopian tube carcinoma


subject: UMLS:C0021741

object_name: fallopian tube cancer


subject: CHEBI:79699

subject_name: Temsirolimus

object_name: recurrent islet cell carcinoma


subject: CHEBI:79699

object_name: metastatic gastrointestinal carcinoid tumor


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: unspecified childhood solid tumor, protocol specific


subject: CHEBI:27812

subject_name: Methylselenocysteine

object_name: ankylosing spondylitis


subject: PUBCHEM.COMPOUND:45480413

object_name: plasma cell myeloma


subject: UMLS:C2981815

subject_name: Dalantercept


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: refractory hematologic cancer


subject: CHEBI:46195

object_name: Recurrent Hematologic Malignancy


subject: CHEBI:46195

object_name: Refractory Acute Leukemia


subject: CHEBI:46195

object_name: Refractory Hodgkin Lymphoma


subject: CHEBI:46195

object_name: Refractory Childhood Hodgkin Lymphoma


subject: CHEBI:46195

object_name: refractory hairy cell leukemia


subject: CHEBI:46195

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:46195

object_name: Refractory T Acute Lymphoblastic Leukemia


subject: CHEBI:46195

object_name: Refractory B Acute Lymphoblastic Leukemia


subject: CHEBI:46195

object_name: Refractory Blastic Plasmacytoid Dendritic Cell Neoplasm


subject: CHEBI:46195

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:46195

object_name: Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm


subject: CHEBI:46195

object_name: Recurrent B Acute Lymphoblastic Leukemia


subject: CHEBI:46195

object_name: Recurrent Childhood T Acute Lymphoblastic Leukemia


subject: CHEBI:46195

object_name: Recurrent T Acute Lymphoblastic Leukemia


subject: CHEBI:46195

object_name: Recurrent Hodgkin Lymphoma


subject: CHEBI:46195

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: CHEBI:46195

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:46195

object_name: Recurrent Acute Leukemia


subject: CHEBI:46195

object_name: systemic mastocytosis


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]

object_name: refractory hematologic cancer


subject: UMLS:C2917659

object_name: Recurrent Hematologic Malignancy


subject: UMLS:C2917659

object_name: Refractory Acute Leukemia


subject: UMLS:C2917659

object_name: Refractory Hodgkin Lymphoma


subject: UMLS:C2917659

object_name: Refractory Childhood Hodgkin Lymphoma


subject: UMLS:C2917659

object_name: refractory hairy cell leukemia


subject: UMLS:C2917659

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: UMLS:C2917659

object_name: Refractory T Acute Lymphoblastic Leukemia


subject: UMLS:C2917659

object_name: Refractory B Acute Lymphoblastic Leukemia


subject: UMLS:C2917659

object_name: Refractory Blastic Plasmacytoid Dendritic Cell Neoplasm


subject: UMLS:C2917659

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: UMLS:C2917659

object_name: Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm


subject: UMLS:C2917659

object_name: Recurrent B Acute Lymphoblastic Leukemia


subject: UMLS:C2917659

object_name: Recurrent Childhood T Acute Lymphoblastic Leukemia


subject: UMLS:C2917659

object_name: Recurrent T Acute Lymphoblastic Leukemia


subject: UMLS:C2917659

object_name: Recurrent Hodgkin Lymphoma


subject: UMLS:C2917659

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: UMLS:C2917659

object_name: Recurrent Adult Hodgkin Lymphoma


subject: UMLS:C2917659

object_name: Recurrent Acute Leukemia


subject: UMLS:C2917659

object_name: systemic mastocytosis


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: refractory hematologic cancer


subject: CHEBI:41879

object_name: Recurrent Hematologic Malignancy


subject: CHEBI:41879

object_name: Refractory Acute Leukemia


subject: CHEBI:41879

object_name: Refractory Hodgkin Lymphoma


subject: CHEBI:41879

object_name: Refractory Childhood Hodgkin Lymphoma


subject: CHEBI:41879

object_name: refractory hairy cell leukemia


subject: CHEBI:41879

object_name: Refractory T Acute Lymphoblastic Leukemia


subject: CHEBI:41879

object_name: Refractory Blastic Plasmacytoid Dendritic Cell Neoplasm


subject: CHEBI:41879

object_name: Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:4636

subject_name: Diphenhydramine


subject: CHEBI:4636


subject: CHEBI:4636


subject: CHEBI:4636


subject: CHEBI:4636


subject: CHEBI:4636


subject: CHEBI:4636

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:4636


subject: CHEBI:4636

object_name: Refractory B Acute Lymphoblastic Leukemia


subject: CHEBI:4636


subject: CHEBI:4636

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:4636


subject: CHEBI:4636

object_name: Recurrent B Acute Lymphoblastic Leukemia


subject: CHEBI:4636

object_name: Recurrent Childhood T Acute Lymphoblastic Leukemia


subject: CHEBI:4636

object_name: Recurrent T Acute Lymphoblastic Leukemia


subject: CHEBI:4636

object_name: Recurrent Hodgkin Lymphoma


subject: CHEBI:4636

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: CHEBI:4636

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:4636

object_name: Recurrent Acute Leukemia


subject: CHEBI:4636

object_name: systemic mastocytosis


subject: UNII:0AHT0IC02G

subject_name: FLOTETUZUMAB

object_name: refractory hematologic cancer


subject: UNII:0AHT0IC02G

object_name: Recurrent Hematologic Malignancy


subject: UNII:0AHT0IC02G

object_name: Refractory Acute Leukemia


subject: UNII:0AHT0IC02G

object_name: Refractory Hodgkin Lymphoma


subject: UNII:0AHT0IC02G

object_name: Refractory Childhood Hodgkin Lymphoma


subject: UNII:0AHT0IC02G

object_name: refractory hairy cell leukemia


subject: UNII:0AHT0IC02G

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: UNII:0AHT0IC02G

object_name: Refractory T Acute Lymphoblastic Leukemia


subject: UNII:0AHT0IC02G

object_name: Refractory B Acute Lymphoblastic Leukemia


subject: UNII:0AHT0IC02G

object_name: Refractory Blastic Plasmacytoid Dendritic Cell Neoplasm


subject: UNII:0AHT0IC02G

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: UNII:0AHT0IC02G

object_name: Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm


subject: UNII:0AHT0IC02G

object_name: Recurrent B Acute Lymphoblastic Leukemia


subject: UNII:0AHT0IC02G

object_name: Recurrent Childhood T Acute Lymphoblastic Leukemia


subject: UNII:0AHT0IC02G

object_name: Recurrent T Acute Lymphoblastic Leukemia


subject: UNII:0AHT0IC02G

object_name: Recurrent Hodgkin Lymphoma


subject: UNII:0AHT0IC02G

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: UNII:0AHT0IC02G

object_name: Recurrent Adult Hodgkin Lymphoma


subject: UNII:0AHT0IC02G

object_name: Recurrent Acute Leukemia


subject: UNII:0AHT0IC02G

object_name: systemic mastocytosis


subject: UMLS:C3896731

subject_name: Flotetuzumab

object_name: refractory hematologic cancer


subject: UMLS:C3896731

object_name: Recurrent Hematologic Malignancy


subject: UMLS:C3896731

object_name: Refractory Acute Leukemia


subject: UMLS:C3896731

object_name: Refractory Hodgkin Lymphoma


subject: UMLS:C3896731

object_name: Refractory Childhood Hodgkin Lymphoma


subject: UMLS:C3896731

object_name: refractory hairy cell leukemia


subject: UMLS:C3896731

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: UMLS:C3896731

object_name: Refractory T Acute Lymphoblastic Leukemia


subject: UMLS:C3896731

object_name: Refractory B Acute Lymphoblastic Leukemia


subject: UMLS:C3896731

object_name: Refractory Blastic Plasmacytoid Dendritic Cell Neoplasm


subject: UMLS:C3896731

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: UMLS:C3896731

object_name: Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm


subject: UMLS:C3896731

object_name: Recurrent B Acute Lymphoblastic Leukemia


subject: UMLS:C3896731

object_name: Recurrent Childhood T Acute Lymphoblastic Leukemia


subject: UMLS:C3896731

object_name: Recurrent T Acute Lymphoblastic Leukemia


subject: UMLS:C3896731

object_name: Recurrent Hodgkin Lymphoma


subject: UMLS:C3896731

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: UMLS:C3896731

object_name: Recurrent Adult Hodgkin Lymphoma


subject: UMLS:C3896731

object_name: Recurrent Acute Leukemia


subject: UMLS:C3896731

object_name: systemic mastocytosis


subject: CHEBI:132922

object_name: refractory hematologic cancer


subject: CHEBI:132922

object_name: Recurrent Hematologic Malignancy


subject: CHEBI:132922

object_name: Refractory Acute Leukemia


subject: CHEBI:132922

object_name: Refractory Hodgkin Lymphoma


subject: CHEBI:132922

object_name: Refractory Childhood Hodgkin Lymphoma


subject: CHEBI:132922

object_name: refractory hairy cell leukemia


subject: CHEBI:132922

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:132922

object_name: Refractory T Acute Lymphoblastic Leukemia


subject: CHEBI:132922

object_name: Refractory B Acute Lymphoblastic Leukemia


subject: CHEBI:132922

object_name: Refractory Blastic Plasmacytoid Dendritic Cell Neoplasm


subject: CHEBI:132922

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:132922

object_name: Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm


subject: CHEBI:132922

object_name: Recurrent B Acute Lymphoblastic Leukemia


subject: CHEBI:132922

object_name: Recurrent Childhood T Acute Lymphoblastic Leukemia


subject: CHEBI:132922

object_name: Recurrent T Acute Lymphoblastic Leukemia


subject: CHEBI:132922

object_name: Recurrent Hodgkin Lymphoma


subject: CHEBI:132922

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: CHEBI:132922

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:132922

object_name: Recurrent Acute Leukemia


subject: CHEBI:132922

object_name: systemic mastocytosis


subject: CHEBI:43415

subject_name: Dexibuprofen

object_name: refractory hematologic cancer


subject: CHEBI:43415

object_name: Recurrent Hematologic Malignancy


subject: CHEBI:43415

object_name: Refractory Acute Leukemia


subject: CHEBI:43415

object_name: Refractory Hodgkin Lymphoma


subject: CHEBI:43415

object_name: Refractory Childhood Hodgkin Lymphoma


subject: CHEBI:43415

object_name: refractory hairy cell leukemia


subject: CHEBI:43415

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:43415

object_name: Refractory T Acute Lymphoblastic Leukemia


subject: CHEBI:43415

object_name: Refractory B Acute Lymphoblastic Leukemia


subject: CHEBI:43415

object_name: Refractory Blastic Plasmacytoid Dendritic Cell Neoplasm


subject: CHEBI:43415

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:43415

object_name: Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm


subject: CHEBI:43415

object_name: Recurrent B Acute Lymphoblastic Leukemia


subject: CHEBI:43415

object_name: Recurrent Childhood T Acute Lymphoblastic Leukemia


subject: CHEBI:43415

object_name: Recurrent T Acute Lymphoblastic Leukemia


subject: CHEBI:43415

object_name: Recurrent Hodgkin Lymphoma


subject: CHEBI:43415

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: CHEBI:43415

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:43415

object_name: Recurrent Acute Leukemia


subject: CHEBI:43415

object_name: systemic mastocytosis


subject: CHEBI:5855

subject_name: Ibuprofen

object_name: refractory hematologic cancer


subject: CHEBI:5855

object_name: Recurrent Hematologic Malignancy


subject: CHEBI:5855

object_name: Refractory Acute Leukemia


subject: CHEBI:5855

object_name: Refractory Hodgkin Lymphoma


subject: CHEBI:5855

object_name: Refractory Childhood Hodgkin Lymphoma


subject: CHEBI:5855

object_name: refractory hairy cell leukemia


subject: CHEBI:5855

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:5855

object_name: Refractory T Acute Lymphoblastic Leukemia


subject: CHEBI:5855

object_name: Refractory B Acute Lymphoblastic Leukemia


subject: CHEBI:5855

object_name: Refractory Blastic Plasmacytoid Dendritic Cell Neoplasm


subject: CHEBI:5855

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:5855

object_name: Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm


subject: CHEBI:5855

object_name: Recurrent B Acute Lymphoblastic Leukemia


subject: CHEBI:5855

object_name: Recurrent Childhood T Acute Lymphoblastic Leukemia


subject: CHEBI:5855

object_name: Recurrent T Acute Lymphoblastic Leukemia


subject: CHEBI:5855

object_name: Recurrent Hodgkin Lymphoma


subject: CHEBI:5855

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: CHEBI:5855

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:5855

object_name: Recurrent Acute Leukemia


subject: CHEBI:5855

object_name: systemic mastocytosis


subject: UNII:884KT10YB7

subject_name: (Z)-ranitidine

object_name: refractory hematologic cancer


subject: UNII:884KT10YB7

object_name: Recurrent Hematologic Malignancy


subject: UNII:884KT10YB7

object_name: Refractory Acute Leukemia


subject: UNII:884KT10YB7

object_name: Refractory Hodgkin Lymphoma


subject: UNII:884KT10YB7

object_name: Refractory Childhood Hodgkin Lymphoma


subject: UNII:884KT10YB7

object_name: refractory hairy cell leukemia


subject: UNII:884KT10YB7

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: UNII:884KT10YB7

object_name: Refractory T Acute Lymphoblastic Leukemia


subject: UNII:884KT10YB7

object_name: Refractory B Acute Lymphoblastic Leukemia


subject: UNII:884KT10YB7

object_name: Refractory Blastic Plasmacytoid Dendritic Cell Neoplasm


subject: UNII:884KT10YB7

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: UNII:884KT10YB7

object_name: Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm


subject: UNII:884KT10YB7

object_name: Recurrent B Acute Lymphoblastic Leukemia


subject: UNII:884KT10YB7

object_name: Recurrent Childhood T Acute Lymphoblastic Leukemia


subject: UNII:884KT10YB7

object_name: Recurrent T Acute Lymphoblastic Leukemia


subject: UNII:884KT10YB7

object_name: Recurrent Hodgkin Lymphoma


subject: UNII:884KT10YB7

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: UNII:884KT10YB7

object_name: Recurrent Adult Hodgkin Lymphoma


subject: UNII:884KT10YB7

object_name: Recurrent Acute Leukemia


subject: UNII:884KT10YB7

object_name: systemic mastocytosis


subject: CHEBI:8776

subject_name: ranitidine

object_name: refractory hematologic cancer


subject: CHEBI:8776

object_name: Recurrent Hematologic Malignancy


subject: CHEBI:8776

object_name: Refractory Acute Leukemia


subject: CHEBI:8776

object_name: Refractory Hodgkin Lymphoma


subject: CHEBI:8776

object_name: Refractory Childhood Hodgkin Lymphoma


subject: CHEBI:8776

object_name: refractory hairy cell leukemia


subject: CHEBI:8776

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:8776

object_name: Refractory T Acute Lymphoblastic Leukemia


subject: CHEBI:8776

object_name: Refractory B Acute Lymphoblastic Leukemia


subject: CHEBI:8776

object_name: Refractory Blastic Plasmacytoid Dendritic Cell Neoplasm


subject: CHEBI:8776

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:8776

object_name: Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm


subject: CHEBI:8776

object_name: Recurrent B Acute Lymphoblastic Leukemia


subject: CHEBI:8776

object_name: Recurrent Childhood T Acute Lymphoblastic Leukemia


subject: CHEBI:8776

object_name: Recurrent T Acute Lymphoblastic Leukemia


subject: CHEBI:8776

object_name: Recurrent Hodgkin Lymphoma


subject: CHEBI:8776

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: CHEBI:8776

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:8776

object_name: Recurrent Acute Leukemia


subject: CHEBI:8776

object_name: systemic mastocytosis


subject: CHEBI:16349

subject_name: Citrulline

object_name: hypertension


subject: CHEBI:16349

object_name: Hypertension, CTCAE


subject: UNII:5ZHA5P4PFX

subject_name: Dalpiciclib

object_name: Advanced breast cancer


subject: UMLS:C3540795

subject_name: ENDOCRINE THERAPY ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS


subject: UMLS:C4760786

object_name: rheumatoid arthritis


subject: UMLS:C3529178

subject_name: pateclizumab


subject: UMLS:C3848704

subject_name: naloxone / oxycodone

object_name: Constipation


subject: UMLS:C3848704

object_name: Constipation, CTCAE


subject: CHEBI:47519

subject_name: Ketoconazole

object_name: Carcinoma breast stage IV


subject: UniProtKB:P41416

subject_name: CXOL_NPVAC Conotoxin-like peptide (sprot)

object_name: cancer


subject: UniProtKB:P41416

object_name: neoplasm


subject: CHEBI:165874


subject: CHEBI:165874


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: mucocutaneous lymph node syndrome


subject: GTOPDB:10609

subject_name: mezagitamab

object_name: kidney disorder


subject: GTOPDB:10609

object_name: impaired renal function disease


subject: CHEMBL.COMPOUND:CHEMBL4297833

subject_name: MEZAGITAMAB


subject: CHEMBL.COMPOUND:CHEMBL4297833


subject: UMLS:C4688355

subject_name: Mezagitamab


subject: UMLS:C4688355


subject: CHEBI:182913

subject_name: Dexpramipexole

object_name: Alzheimer disease


subject: CHEBI:63660

object_name: progeria


subject: CHEBI:63618

subject_name: Pravastatin


subject: UNII:6XC1PAD3KF

subject_name: ZOLEDRONIC ACID


subject: CHEBI:46557

subject_name: Zoledronic acid


subject: UMLS:C5785435

subject_name: San Zhong Kui Jian Tang

object_name: head and neck neoplasm


subject: UMLS:C5785435

object_name: head and neck cancer


subject: PUBCHEM.COMPOUND:129316491

object_name: progressive supranuclear palsy


subject: PUBCHEM.COMPOUND:129316491

object_name: supranuclear palsy, progressive, 1


subject: PUBCHEM.COMPOUND:129316491

object_name: familial spontaneous pneumothorax


subject: PUBCHEM.COMPOUND:129316491

object_name: Pseudoprogression


subject: PUBCHEM.COMPOUND:129316491

object_name: neurodegenerative disease


subject: PUBCHEM.COMPOUND:129316491

object_name: Atypical Parkinsonism


subject: UMLS:C5774003


subject: UMLS:C5774003


subject: UMLS:C5774003


subject: UMLS:C5774003


subject: UMLS:C5774003


subject: UMLS:C5774003


subject: PUBCHEM.COMPOUND:21982135

object_name: digestive system cancer


subject: CHEBI:73038

subject_name: Parecoxib


subject: PUBCHEM.COMPOUND:122491414

object_name: Adult Solid Neoplasm


subject: PUBCHEM.COMPOUND:122491414


subject: UMLS:C5666885

subject_name: Deoxycytidine Kinase Inhibitor TRE-515


subject: UMLS:C5666885


subject: UNII:8EK0RD3M21


subject: UNII:8EK0RD3M21


subject: CHEBI:17823

subject_name: Calcitriol

object_name: Chronic small plaque psoriasis


subject: CHEBI:184910

subject_name: Rotigotine

object_name: Motor Deficit


subject: CHEBI:184910

object_name: Hemispatial Neglect


subject: CHEBI:23359

subject_name: colchicine

object_name: Colchicine adverse reaction


subject: CHEBI:23359

object_name: nonsteroidal anti-inflammatory drugs (NSAIDs) toxicity


subject: CHEBI:35475

subject_name: non-steroidal anti-inflammatory drug

object_name: gout


subject: CHEBI:35475

object_name: kidney failure


subject: CHEBI:35475


subject: CHEBI:35475


subject: UMLS:C0003211

subject_name: Anti-Inflammatory Agents, Non-Steroidal


subject: UMLS:C0003211


subject: UMLS:C0003211


subject: UMLS:C0003211


subject: UMLS:C3536840

subject_name: Nonsteroidal Anti-inflammatory Drug [EPC]


subject: UMLS:C3536840


subject: UMLS:C3536840


subject: UMLS:C5785368

subject_name: KRAS G12D Inhibitor HRS-4642

object_name: biliary tract cancer


subject: UMLS:C5785368

object_name: liver carcinoma


subject: PUBCHEM.COMPOUND:72995949

subject_name: Voclosporin


subject: PUBCHEM.COMPOUND:72995949

object_name: Infection of transplanted kidney


subject: CHEBI:36005

subject_name: docosahexaenoic acid

object_name: inherited lipid metabolism disorder


subject: CHEBI:16016

subject_name: Glycerone


subject: CHEBI:28689

subject_name: Prasterone


subject: CHEBI:28125

subject_name: Doconexent


subject: CHEBI:37144

subject_name: epichlorohydrin


subject: CHEBI:37144

object_name: hypertriglyceridemia


subject: CHEBI:37144

object_name: Hypertriglyceridemia, CTCAE


subject: CHEBI:28364

subject_name: Icosapent


subject: PR:000016352

subject_name: metalloproteinase inhibitor 1


subject: PR:000016352


subject: PR:000016352


subject: PUBCHEM.COMPOUND:135618605

subject_name: poly If

object_name: White Spot Lesion


subject: MESH:D050091

subject_name: Dendrimers


subject: CHEBI:51338

subject_name: dendrimer macromolecule


subject: CHEBI:61483

subject_name: dendritic polymer


subject: CHEBI:27732

subject_name: Caffeine

object_name: congenital alveolar dysplasia


subject: CHEBI:27732

object_name: respiratory distress syndrome in premature infants


subject: CHEBI:27732

object_name: adult acute respiratory distress syndrome


subject: CHEBI:27732

object_name: newborn respiratory distress syndrome


subject: CHEBI:45716

subject_name: Vorinostat

object_name: Advanced breast cancer


subject: UMLS:C4305924

object_name: atopic eczema


subject: UNII:NF3P9Z8J5Y

subject_name: baxdrostat

object_name: Uncontrolled hypertension


subject: UNII:NF3P9Z8J5Y

object_name: resistant hypertension


subject: UNII:NF3P9Z8J5Y

object_name: Hypertension resistant to conventional therapy


subject: DRUGBANK:DB19090

subject_name: Baxdrostat


subject: DRUGBANK:DB19090


subject: DRUGBANK:DB19090


subject: CHEBI:42797

subject_name: Gabapentin

object_name: pervasive developmental disorder


subject: CHEBI:42797

object_name: autism


subject: CHEBI:42797

object_name: autism spectrum disorder


subject: CHEBI:43602

subject_name: Obeticholic acid

object_name: cholecystolithiasis


subject: CHEBI:43602

object_name: gallstones


subject: CHEBI:43602

object_name: cholelithiasis


subject: CHEBI:43602

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:43602

object_name: obesity


subject: CHEBI:43602

object_name: Obesity, CTCAE


subject: UMLS:C5226607

object_name: systemic sclerosis


subject: CHEBI:229764

subject_name: Selinexor

object_name: metastatic colorectal cancer


subject: CHEBI:669

object_name: infertility


subject: CHEBI:184492


subject: CHEBI:30216

subject_name: alpha-particle


subject: UMLS:C5400714

subject_name: ALPHA (substance)


subject: UNII:AC10C1L8VO

subject_name: alpha


subject: PR:000001067

subject_name: transient receptor potential cation channel TRPV1 isoform 1


subject: UMLS:C0003250

subject_name: Monoclonal Antibodies

object_name: glioblastoma


subject: UMLS:C0003250

object_name: Childhood Glioblastoma


subject: UMLS:C0003250

object_name: adult glioblastoma


subject: UMLS:C5203232

subject_name: Monoclonal Antibody [EPC]


subject: UMLS:C5203232


subject: UMLS:C5203232


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Severe Sepsis


subject: UNII:2S9ZZM9Q9V

object_name: acute respiratory distress syndrome


subject: UNII:2S9ZZM9Q9V

object_name: adult acute respiratory distress syndrome


subject: CHEBI:31312

subject_name: Bucillamine

object_name: cystinuria


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: Metastatic Cervical Carcinoma


subject: UNII:28X28X9OKV

object_name: Metastatic Vulvar Carcinoma


subject: UNII:28X28X9OKV

object_name: Metastatic Cervical Adenocarcinoma


subject: UNII:28X28X9OKV

object_name: Recurrent Vulvar Carcinoma


subject: UNII:28X28X9OKV

object_name: Advanced Cervical Adenocarcinoma


subject: UNII:28X28X9OKV

object_name: Advanced Vulvar Carcinoma


subject: UNII:28X28X9OKV

object_name: Metastatic Vaginal Carcinoma


subject: UNII:28X28X9OKV

object_name: Cervix carcinoma recurrent


subject: UNII:28X28X9OKV

object_name: Stage IV Vulvar Cancer AJCC v8


subject: UNII:28X28X9OKV

object_name: Vaginal cancer recurrent


subject: UNII:28X28X9OKV

object_name: Stage III Vulvar Cancer AJCC v8


subject: UNII:28X28X9OKV

object_name: Stage IVB Vulvar Cancer AJCC v8


subject: UNII:28X28X9OKV

object_name: Stage IVA Vulvar Cancer AJCC v8


subject: UNII:28X28X9OKV

object_name: Advanced Vaginal Carcinoma


subject: UNII:28X28X9OKV

object_name: Vaginal adenocarcinoma metastatic


subject: UNII:28X28X9OKV

object_name: Stage IIIB Vulvar Cancer AJCC v8


subject: UNII:28X28X9OKV

object_name: Stage IIIA Vulvar Cancer AJCC v8


subject: UNII:28X28X9OKV

object_name: Stage IIIC Vulvar Cancer AJCC v8


subject: UNII:28X28X9OKV

object_name: Recurrent Cervical Adenocarcinoma


subject: UNII:28X28X9OKV

object_name: Stage IV Cervical Cancer AJCC v8


subject: UNII:28X28X9OKV

object_name: Stage IVA Cervical Cancer AJCC v8


subject: UNII:28X28X9OKV

object_name: Stage III Cervical Cancer AJCC v8


subject: UNII:28X28X9OKV

object_name: Stage IVB Cervical Cancer AJCC v8


subject: UNII:28X28X9OKV

object_name: Stage IV Vaginal Cancer AJCC v8


subject: UNII:28X28X9OKV

object_name: Stage IIIB Cervical Cancer AJCC v8


subject: UNII:28X28X9OKV

object_name: Stage IIIA Cervical Cancer AJCC v8


subject: UNII:28X28X9OKV

object_name: Stage IVA Vaginal Cancer AJCC v8


subject: UNII:28X28X9OKV

object_name: Stage IVB Vaginal Cancer AJCC v8


subject: UNII:28X28X9OKV

object_name: Stage III Vaginal Cancer AJCC v8


subject: UNII:28X28X9OKV

object_name: Human Papillomavirus-Related Cervical Squamous Cell Carcinoma


subject: UNII:28X28X9OKV

object_name: vaginal squamous cell carcinoma


subject: UNII:28X28X9OKV

object_name: vulvar squamous cell carcinoma


subject: UNII:28X28X9OKV

object_name: Human Papillomavirus-Related Vulvar Squamous Cell Carcinoma


subject: UNII:28X28X9OKV

object_name: vulvar adenocarcinoma


subject: UMLS:C3641122

object_name: Metastatic Cervical Carcinoma


subject: UMLS:C3641122

object_name: Metastatic Vulvar Carcinoma


subject: UMLS:C3641122

object_name: Metastatic Cervical Adenocarcinoma


subject: UMLS:C3641122

object_name: Recurrent Vulvar Carcinoma


subject: UMLS:C3641122

object_name: Advanced Cervical Adenocarcinoma


subject: UMLS:C3641122

object_name: Advanced Vulvar Carcinoma


subject: UMLS:C3641122

object_name: Metastatic Vaginal Carcinoma


subject: UMLS:C3641122

object_name: Cervix carcinoma recurrent


subject: UMLS:C3641122

object_name: Stage IV Vulvar Cancer AJCC v8


subject: UMLS:C3641122

object_name: Vaginal cancer recurrent


subject: UMLS:C3641122

object_name: Stage III Vulvar Cancer AJCC v8


subject: UMLS:C3641122

object_name: Stage IVB Vulvar Cancer AJCC v8


subject: UMLS:C3641122

object_name: Stage IVA Vulvar Cancer AJCC v8


subject: UMLS:C3641122

object_name: Advanced Vaginal Carcinoma


subject: UMLS:C3641122

object_name: Vaginal adenocarcinoma metastatic


subject: UMLS:C3641122

object_name: Stage IIIB Vulvar Cancer AJCC v8


subject: UMLS:C3641122

object_name: Stage IIIA Vulvar Cancer AJCC v8


subject: UMLS:C3641122

object_name: Stage IIIC Vulvar Cancer AJCC v8


subject: UMLS:C3641122

object_name: Recurrent Cervical Adenocarcinoma


subject: UMLS:C3641122

object_name: Stage IV Cervical Cancer AJCC v8


subject: UMLS:C3641122

object_name: Stage IVA Cervical Cancer AJCC v8


subject: UMLS:C3641122

object_name: Stage III Cervical Cancer AJCC v8


subject: UMLS:C3641122

object_name: Stage IVB Cervical Cancer AJCC v8


subject: UMLS:C3641122

object_name: Stage IV Vaginal Cancer AJCC v8


subject: UMLS:C3641122

object_name: Stage IIIB Cervical Cancer AJCC v8


subject: UMLS:C3641122

object_name: Stage IIIA Cervical Cancer AJCC v8


subject: UMLS:C3641122

object_name: Stage IVA Vaginal Cancer AJCC v8


subject: UMLS:C3641122

object_name: Stage IVB Vaginal Cancer AJCC v8


subject: UMLS:C3641122

object_name: Stage III Vaginal Cancer AJCC v8


subject: UMLS:C3641122

object_name: Human Papillomavirus-Related Cervical Squamous Cell Carcinoma


subject: UMLS:C3641122

object_name: vaginal squamous cell carcinoma


subject: UMLS:C3641122

object_name: vulvar squamous cell carcinoma


subject: UMLS:C3641122

object_name: Human Papillomavirus-Related Vulvar Squamous Cell Carcinoma


subject: UMLS:C3641122

object_name: vulvar adenocarcinoma


subject: UNII:QEN1X95CIX

subject_name: Tremelimumab

object_name: Metastatic Cervical Carcinoma


subject: UNII:QEN1X95CIX

object_name: Metastatic Vulvar Carcinoma


subject: UNII:QEN1X95CIX

object_name: Metastatic Cervical Adenocarcinoma


subject: UNII:QEN1X95CIX

object_name: Recurrent Vulvar Carcinoma


subject: UNII:QEN1X95CIX

object_name: Advanced Cervical Adenocarcinoma


subject: UNII:QEN1X95CIX

object_name: Advanced Vulvar Carcinoma


subject: UNII:QEN1X95CIX

object_name: Metastatic Vaginal Carcinoma


subject: UNII:QEN1X95CIX

object_name: Cervix carcinoma recurrent


subject: UNII:QEN1X95CIX

object_name: Stage IV Vulvar Cancer AJCC v8


subject: UNII:QEN1X95CIX

object_name: Vaginal cancer recurrent


subject: UNII:QEN1X95CIX

object_name: Stage III Vulvar Cancer AJCC v8


subject: UNII:QEN1X95CIX

object_name: Stage IVB Vulvar Cancer AJCC v8


subject: UNII:QEN1X95CIX

object_name: Stage IVA Vulvar Cancer AJCC v8


subject: UNII:QEN1X95CIX

object_name: Advanced Vaginal Carcinoma


subject: UNII:QEN1X95CIX

object_name: Vaginal adenocarcinoma metastatic


subject: UNII:QEN1X95CIX

object_name: Stage IIIB Vulvar Cancer AJCC v8


subject: UNII:QEN1X95CIX

object_name: Stage IIIA Vulvar Cancer AJCC v8


subject: UNII:QEN1X95CIX

object_name: Stage IIIC Vulvar Cancer AJCC v8


subject: UNII:QEN1X95CIX

object_name: Recurrent Cervical Adenocarcinoma


subject: UNII:QEN1X95CIX

object_name: Stage IV Cervical Cancer AJCC v8


subject: UNII:QEN1X95CIX

object_name: Stage IVA Cervical Cancer AJCC v8


subject: UNII:QEN1X95CIX

object_name: Stage III Cervical Cancer AJCC v8


subject: UNII:QEN1X95CIX

object_name: Stage IVB Cervical Cancer AJCC v8


subject: UNII:QEN1X95CIX

object_name: Stage IV Vaginal Cancer AJCC v8


subject: UNII:QEN1X95CIX

object_name: Stage IIIB Cervical Cancer AJCC v8


subject: UNII:QEN1X95CIX

object_name: Stage IIIA Cervical Cancer AJCC v8


subject: UNII:QEN1X95CIX

object_name: Stage IVA Vaginal Cancer AJCC v8


subject: UNII:QEN1X95CIX

object_name: Stage IVB Vaginal Cancer AJCC v8


subject: UNII:QEN1X95CIX

object_name: Stage III Vaginal Cancer AJCC v8


subject: UNII:QEN1X95CIX

object_name: Human Papillomavirus-Related Cervical Squamous Cell Carcinoma


subject: UNII:QEN1X95CIX

object_name: vaginal squamous cell carcinoma


subject: UNII:QEN1X95CIX

object_name: vulvar squamous cell carcinoma


subject: UNII:QEN1X95CIX

object_name: Human Papillomavirus-Related Vulvar Squamous Cell Carcinoma


subject: UNII:QEN1X95CIX

object_name: vulvar adenocarcinoma


subject: UMLS:C1948073

object_name: Metastatic Cervical Carcinoma


subject: UMLS:C1948073

object_name: Metastatic Vulvar Carcinoma


subject: UMLS:C1948073

object_name: Metastatic Cervical Adenocarcinoma


subject: UMLS:C1948073

object_name: Recurrent Vulvar Carcinoma


subject: UMLS:C1948073

object_name: Advanced Cervical Adenocarcinoma


subject: UMLS:C1948073

object_name: Advanced Vulvar Carcinoma


subject: UMLS:C1948073

object_name: Metastatic Vaginal Carcinoma


subject: UMLS:C1948073

object_name: Cervix carcinoma recurrent


subject: UMLS:C1948073

object_name: Stage IV Vulvar Cancer AJCC v8


subject: UMLS:C1948073

object_name: Vaginal cancer recurrent


subject: UMLS:C1948073

object_name: Stage III Vulvar Cancer AJCC v8


subject: UMLS:C1948073

object_name: Stage IVB Vulvar Cancer AJCC v8


subject: UMLS:C1948073

object_name: Stage IVA Vulvar Cancer AJCC v8


subject: UMLS:C1948073

object_name: Advanced Vaginal Carcinoma


subject: UMLS:C1948073

object_name: Vaginal adenocarcinoma metastatic


subject: UMLS:C1948073

object_name: Stage IIIB Vulvar Cancer AJCC v8


subject: UMLS:C1948073

object_name: Stage IIIA Vulvar Cancer AJCC v8


subject: UMLS:C1948073

object_name: Stage IIIC Vulvar Cancer AJCC v8


subject: UMLS:C1948073

object_name: Recurrent Cervical Adenocarcinoma


subject: UMLS:C1948073

object_name: Stage IV Cervical Cancer AJCC v8


subject: UMLS:C1948073

object_name: Stage IVA Cervical Cancer AJCC v8


subject: UMLS:C1948073

object_name: Stage III Cervical Cancer AJCC v8


subject: UMLS:C1948073

object_name: Stage IVB Cervical Cancer AJCC v8


subject: UMLS:C1948073

object_name: Stage IV Vaginal Cancer AJCC v8


subject: UMLS:C1948073

object_name: Stage IIIB Cervical Cancer AJCC v8


subject: UMLS:C1948073

object_name: Stage IIIA Cervical Cancer AJCC v8


subject: UMLS:C1948073

object_name: Stage IVA Vaginal Cancer AJCC v8


subject: UMLS:C1948073

object_name: Stage IVB Vaginal Cancer AJCC v8


subject: UMLS:C1948073

object_name: Stage III Vaginal Cancer AJCC v8


subject: UMLS:C1948073

object_name: Human Papillomavirus-Related Cervical Squamous Cell Carcinoma


subject: UMLS:C1948073

object_name: vaginal squamous cell carcinoma


subject: UMLS:C1948073

object_name: vulvar squamous cell carcinoma


subject: UMLS:C1948073

object_name: Human Papillomavirus-Related Vulvar Squamous Cell Carcinoma


subject: UMLS:C1948073

object_name: vulvar adenocarcinoma


subject: CHEBI:16480

subject_name: Nitric Oxide

object_name: Mycobacterium abscessus Infection


subject: UNII:2P3VWU3H10

subject_name: ACTIVATED CHARCOAL

object_name: phenytoin toxicity


subject: CHEBI:27594

subject_name: Graphite


subject: UMLS:C0723575

subject_name: T-Diet

object_name: acute pancreatitis


subject: PR:000001151

subject_name: Toll-like receptor 1

object_name: glioma


subject: PR:000001151

object_name: malignant glioma


subject: CHEBI:125354

subject_name: Plerixafor

object_name: Adult Hodgkin Lymphoma


subject: CHEBI:125354

object_name: Childhood Hodgkin Lymphoma


subject: GTOPDB:13607

subject_name: danvatirsen

object_name: head and neck squamous cell carcinoma


subject: UNII:31N550RD05

subject_name: Danvatirsen


subject: CHEBI:28748

subject_name: Doxorubicin

object_name: Recurrent Ovarian Low Grade Serous Adenocarcinoma


subject: CHEBI:28748

object_name: high grade ovarian serous adenocarcinoma


subject: CHEBI:28748

object_name: Recurrent Ovarian Carcinosarcoma


subject: CHEBI:28748

object_name: Recurrent Ovarian Clear Cell Adenocarcinoma


subject: CHEBI:28748

object_name: Recurrent Ovarian Transitional Cell Carcinoma


subject: CHEBI:28748

object_name: Fallopian Tube High Grade Serous Adenocarcinoma


subject: CHEBI:28748

object_name: Recurrent Ovarian Mucinous Adenocarcinoma


subject: CHEBI:28748

object_name: Recurrent Ovarian Endometrioid Adenocarcinoma


subject: CHEBI:28748

object_name: Primary Peritoneal High Grade Serous Adenocarcinoma


subject: CHEBI:28748

object_name: Platinum-Sensitive Ovarian Carcinoma


subject: CHEBI:28748

object_name: Recurrent Primary Peritoneal Low Grade Serous Adenocarcinoma


subject: CHEBI:28748

object_name: Recurrent Low Grade Fallopian Tube Serous Adenocarcinoma


subject: CHEBI:28748

object_name: Endometrial High Grade Endometrioid Adenocarcinoma


subject: CHEBI:28748

object_name: Undifferentiated Fallopian Tube Carcinoma


subject: CHEBI:28748

object_name: Primary Peritoneal Undifferentiated Carcinoma


subject: CHEBI:28748

object_name: FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma